Cecha
Cross-eyed
Nazwa kliniczna: Strabismus
A misalignment of the eyes so that the visual axes deviate from bifoveal fixation. The classification of strabismus may be based on a number of features including the relative position of the eyes, whether the deviation is latent or manifest, intermittent or constant, concomitant or otherwise and according to the age of onset and the relevance of any associated refractive error.
Podsumowanie
- Znana także jako
- Squint, Squint eyes
- Układ organizmu
- Abnormality of the eye
Genom referencyjnyGRCh38hg38
Pozycje na stronach genów i wariantów zależą od tego wyboru, w tej przeglądarce.
Read the genes linked to Cross-eyed, and the rest of your genome, with one test.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni
Zamawiam Genome Test1065 genów powiązanych z Cross-eyed
Zmiany w tych genach powodują rzadkie choroby, w których występuje Cross-eyed. Większość osób z tą cechą nie ma żadnej z tych chorób, a gen z tej listy nic nie mówi o czyimkolwiek własnym genomie.
| Gen | Jak często występuje | Choroby |
|---|---|---|
| ABCA4ATP binding cassette subfamily A member 4 | Zawsze | W 1 chorobie |
| ABCB7ATP binding cassette subfamily B member 7 | Zawsze | W 2 chorobach |
| ADAMTS3ADAM metallopeptidase with thrombospondin type 1 motif 3 | Zawsze | W 1 chorobie |
| ALX4ALX homeobox 4 | Zawsze | W 3 chorobach |
| ANTXR1ANTXR cell adhesion molecule 1 | Zawsze | W 1 chorobie |
| ARHGEF2Rho/Rac guanine nucleotide exchange factor 2 | Zawsze | W 1 chorobie |
| ARID1AAT-rich interaction domain 1A | Zawsze | W 2 chorobach |
| ASH1LASH1 like histone lysine methyltransferase | Zawsze | W 1 chorobie |
| ATP6V1E1ATPase H+ transporting V1 subunit E1 | Zawsze | W 2 chorobach |
| BCL11ABCL11 transcription factor A | Zawsze | W 2 chorobach |
| CAMK2Gcalcium/calmodulin dependent protein kinase II gamma | Zawsze | W 1 chorobie |
| CC2D2Acoiled-coil and C2 domain containing 2A | Zawsze | W 3 chorobach |
| CLDN11claudin 11 | Zawsze | W 1 chorobie |
| CLP1cleavage factor polyribonucleotide kinase subunit 1 | Zawsze | W 2 chorobach |
| CNTNAP2contactin associated protein 2 | Zawsze | W 1 chorobie |
| COL4A2collagen type IV alpha 2 chain | Zawsze | W 1 chorobie |
| CPAPcentrosome assembly and centriole elongation protein | Zawsze | W 1 chorobie |
| CREBBPCREB binding lysine acetyltransferase | Zawsze | W 4 chorobach |
| CRELD1CRELD disulfide isomerase 1 | Zawsze | W 1 chorobie |
| CRNKL1crooked neck pre-mRNA splicing factor 1 | Zawsze | W 1 chorobie |
| CWF19L1CWF19 like cell cycle control factor 1 | Zawsze | W 1 chorobie |
| DDOSTdolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit | Zawsze | W 1 chorobie |
| EP300EP300 lysine acetyltransferase | Zawsze | W 4 chorobach |
| ERI1exoribonuclease 1 | Zawsze | W 1 chorobie |
| ERMARDER membrane associated RNA degradation | Zawsze | W 2 chorobach |
| EXOSC1exosome component 1 | Zawsze | W 1 chorobie |
| FAM149B1family with sequence similarity 149 member B1 | Zawsze | W 1 chorobie |
| FBXO11F-box protein 11 | Zawsze | W 1 chorobie |
| FBXO28F-box protein 28 | Zawsze | W 1 chorobie |
| FDXRferredoxin reductase | Zawsze | W 1 chorobie |
| GANgigaxonin | Zawsze | W 1 chorobie |
| GATAD2BGATA zinc finger domain containing 2B | Zawsze | W 2 chorobach |
| GOLGA2golgin A2 | Zawsze | W 1 chorobie |
| GON4Lgon-4 like | Zawsze | W 1 chorobie |
| GRM1glutamate metabotropic receptor 1 | Zawsze | W 1 chorobie |
| GTPBP1GTP binding protein 1 | Zawsze | W 1 chorobie |
| HSPD1heat shock protein family D (Hsp60) member 1 | Zawsze | W 1 chorobie |
| INPP4Ainositol polyphosphate-4-phosphatase type I A | Zawsze | W 1 chorobie |
| INPP5Einositol polyphosphate-5-phosphatase E | Zawsze | W 4 chorobach |
| INTS11integrator complex subunit 11 | Zawsze | W 1 chorobie |
Pokaż jeszcze 1025 genów
| Gen | Jak często występuje | Choroby |
|---|---|---|
| ITPR1inositol 1,4,5-trisphosphate receptor type 1 | Zawsze | W 1 chorobie |
| JKAMPJNK1/MAPK8 associated membrane protein | Zawsze | W 1 chorobie |
| KDM2Blysine demethylase 2B | Zawsze | W 1 chorobie |
| LBRlamin B receptor | Zawsze | W 1 chorobie |
| LGI4leucine rich repeat LGI family member 4 | Zawsze | W 1 chorobie |
| LRRC7leucine rich repeat containing 7 | Zawsze | W 1 chorobie |
| LSM7LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated | Zawsze | W 1 chorobie |
| MAB21L1mab-21 like 1 | Zawsze | W 2 chorobach |
| MAN2B2mannosidase alpha class 2B member 2 | Zawsze | W 1 chorobie |
| MAP2K2mitogen-activated protein kinase kinase 2 | Zawsze | W 3 chorobach |
| MYT1Lmyelin transcription factor 1 like | Zawsze | W 2 chorobach |
| NALCNsodium leak channel, non-selective | Zawsze | W 4 chorobach |
| NEXMIFneurite extension and migration factor | Zawsze | W 1 chorobie |
| NHEJ1non-homologous end joining factor 1 | Zawsze | W 1 chorobie |
| NR2F1nuclear receptor subfamily 2 group F member 1 | Zawsze | W 2 chorobach |
| NR6A1nuclear receptor subfamily 6 group A member 1 | Zawsze | W 1 chorobie |
| NUBPLNUBP iron-sulfur cluster assembly factor, mitochondrial | Zawsze | W 2 chorobach |
| NUP133nucleoporin 133 | Zawsze | W 1 chorobie |
| P4HTMprolyl 4-hydroxylase, transmembrane | Zawsze | W 1 chorobie |
| PDCD6IPprogrammed cell death 6 interacting protein | Zawsze | W 1 chorobie |
| PEX11Bperoxisomal biogenesis factor 11 beta | Zawsze | W 2 chorobach |
| PIGTphosphatidylinositol glycan anchor biosynthesis class T | Zawsze | W 2 chorobach |
| PIGUphosphatidylinositol glycan anchor biosynthesis class U | Zawsze | W 1 chorobie |
| PPFIA3PPFI scaffold protein A3 | Zawsze | W 1 chorobie |
| PRPS1phosphoribosyl pyrophosphate synthetase 1 | Zawsze | W 1 chorobie |
| PUS3pseudouridine synthase 3 | Zawsze | W 2 chorobach |
| RAI1retinoic acid induced 1 | Zawsze | W 3 chorobach |
| RFC4replication factor C subunit 4 | Zawsze | W 1 chorobie |
| RNF2ring finger protein 2 | Zawsze | W 1 chorobie |
| RNU6ATACRNA, U6atac small nuclear | Zawsze | W 1 chorobie |
| RPS6KC1ribosomal protein S6 kinase C1 | Zawsze | W 1 chorobie |
| SCN4Asodium voltage-gated channel alpha subunit 4 | Zawsze | W 2 chorobach |
| SCN8Asodium voltage-gated channel alpha subunit 8 | Zawsze | W 1 chorobie |
| SCO2synthesis of cytochrome C oxidase 2 | Zawsze | W 1 chorobie |
| SF3B4splicing factor 3b subunit 4 | Zawsze | W 1 chorobie |
| SIN3ASIN3 transcription regulator family member A | Zawsze | W 2 chorobach |
| SLC13A1solute carrier family 13 member 1 | Zawsze | W 1 chorobie |
| SLC30A9solute carrier family 30 member 9 | Zawsze | W 1 chorobie |
| SLC37A4solute carrier family 37 member 4 | Zawsze | W 1 chorobie |
| SLC9A6solute carrier family 9 member A6 | Zawsze | W 2 chorobach |
| SPTBN2spectrin beta, non-erythrocytic 2 | Zawsze | W 2 chorobach |
| SYNE1spectrin repeat containing nuclear envelope protein 1 | Zawsze | W 4 chorobach |
| TBCBtubulin folding cofactor B | Zawsze | W 1 chorobie |
| TGFBR1transforming growth factor beta receptor 1 | Zawsze | W 1 chorobie |
| TIMM50translocase of inner mitochondrial membrane 50 | Zawsze | W 1 chorobie |
| TMEM216transmembrane protein 216 | Zawsze | W 2 chorobach |
| TOR1Atorsin family 1 member A | Zawsze | W 1 chorobie |
| TUBB3tubulin beta 3 class III | Zawsze | W 4 chorobach |
| UBA2ubiquitin like modifier activating enzyme 2 | Zawsze | W 1 chorobie |
| UGGT1UDP-glucose glycoprotein glucosyltransferase 1 | Zawsze | W 1 chorobie |
| UNC13Aunc-13 homolog A | Zawsze | W 1 chorobie |
| VLDLRvery low density lipoprotein receptor | Zawsze | W 2 chorobach |
| VPS51VPS51 subunit of GARP complex | Zawsze | W 1 chorobie |
| VPS53VPS53 subunit of GARP complex | Zawsze | W 1 chorobie |
| ZNF407zinc finger protein 407 | Zawsze | W 1 chorobie |
| ADAT3adenosine deaminase tRNA specific 3 | Bardzo często (80–99%) | W 2 chorobach |
| AGKacylglycerol kinase | Bardzo często (80–99%) | W 2 chorobach |
| ALDH1A3aldehyde dehydrogenase 1 family member A3 | Bardzo często (80–99%) | W 1 chorobie |
| AP1S2adaptor related protein complex 1 subunit sigma 2 | Bardzo często (80–99%) | W 1 chorobie |
| ASCL1achaete-scute family bHLH transcription factor 1 | Bardzo często (80–99%) | W 1 chorobie |
| ATCAYATCAY kinesin light chain interacting caytaxin | Bardzo często (80–99%) | W 1 chorobie |
| ATMATM serine/threonine kinase | Bardzo często (80–99%) | W 2 chorobach |
| ATP13A2ATPase cation transporting 13A2 | Bardzo często (80–99%) | W 1 chorobie |
| B3GALNT2beta-1,3-N-acetylgalactosaminyltransferase 2 | Bardzo często (80–99%) | W 1 chorobie |
| BCAP31B cell receptor associated protein 31 | Bardzo często (80–99%) | W 3 chorobach |
| BEST1bestrophin 1 | Bardzo często (80–99%) | W 2 chorobach |
| CDH11cadherin 11 | Bardzo często (80–99%) | W 2 chorobach |
| CHN1chimerin 1 | Bardzo często (80–99%) | W 2 chorobach |
| CHST14carbohydrate sulfotransferase 14 | Bardzo często (80–99%) | W 2 chorobach |
| COL25A1collagen type XXV alpha 1 chain | Bardzo często (80–99%) | W 1 chorobie |
| CRB1crumbs cell polarity complex component 1 | Bardzo często (80–99%) | W 1 chorobie |
| CRPPACDP-L-ribitol pyrophosphorylase A | Bardzo często (80–99%) | W 1 chorobie |
| CTDP1CTD phosphatase 1 | Bardzo często (80–99%) | W 1 chorobie |
| EBF3EBF transcription factor 3 | Bardzo często (80–99%) | W 2 chorobach |
| FKRPfukutin related protein | Bardzo często (80–99%) | W 3 chorobach |
| FKTNfukutin | Bardzo często (80–99%) | W 2 chorobach |
| FOXRED1FAD dependent oxidoreductase domain containing 1 | Bardzo często (80–99%) | W 1 chorobie |
| GBA1glucosylceramidase beta 1 | Bardzo często (80–99%) | W 7 chorobach |
| GGCXgamma-glutamyl carboxylase | Bardzo często (80–99%) | W 1 chorobie |
| GJC2gap junction protein gamma 2 | Bardzo często (80–99%) | W 2 chorobach |
| GMPPBGDP-mannose pyrophosphorylase B | Bardzo często (80–99%) | W 4 chorobach |
| KIF21Akinesin family member 21A | Bardzo często (80–99%) | W 1 chorobie |
| LARGE1LARGE xylosyl- and glucuronyltransferase 1 | Bardzo często (80–99%) | W 2 chorobach |
| MAFBMAF bZIP transcription factor B | Bardzo często (80–99%) | W 1 chorobie |
| MCOLN1mucolipin TRP cation channel 1 | Bardzo często (80–99%) | W 2 chorobach |
| MFRPmembrane frizzled-related protein | Bardzo często (80–99%) | W 1 chorobie |
| MT-ND1mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 | Bardzo często (80–99%) | W 1 chorobie |
| MT-ND2mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 | Bardzo często (80–99%) | W 1 chorobie |
| MT-ND3mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3 | Bardzo często (80–99%) | W 1 chorobie |
| NAGAalpha-N-acetylgalactosaminidase | Bardzo często (80–99%) | W 3 chorobach |
| NDPnorrin cystine knot growth factor NDP | Bardzo często (80–99%) | W 3 chorobach |
| NDUFA1NADH:ubiquinone oxidoreductase subunit A1 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFA11NADH:ubiquinone oxidoreductase subunit A11 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFA6NADH:ubiquinone oxidoreductase subunit A6 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFA9NADH:ubiquinone oxidoreductase subunit A9 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFAF1NADH:ubiquinone oxidoreductase complex assembly factor 1 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFAF2NADH:ubiquinone oxidoreductase complex assembly factor 2 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFAF3NADH:ubiquinone oxidoreductase complex assembly factor 3 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFAF4NADH:ubiquinone oxidoreductase complex assembly factor 4 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFAF5NADH:ubiquinone oxidoreductase complex assembly factor 5 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFAF8NADH:ubiquinone oxidoreductase complex assembly factor 8 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFB10NADH:ubiquinone oxidoreductase subunit B10 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFB11NADH:ubiquinone oxidoreductase subunit B11 | Bardzo często (80–99%) | W 2 chorobach |
| NDUFB3NADH:ubiquinone oxidoreductase subunit B3 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFB9NADH:ubiquinone oxidoreductase subunit B9 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFS1NADH:ubiquinone oxidoreductase core subunit S1 | Bardzo często (80–99%) | W 2 chorobach |
| NDUFS2NADH:ubiquinone oxidoreductase core subunit S2 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFS3NADH:ubiquinone oxidoreductase core subunit S3 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFS4NADH:ubiquinone oxidoreductase subunit S4 | Bardzo często (80–99%) | W 2 chorobach |
| NDUFS6NADH:ubiquinone oxidoreductase subunit S6 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFS7NADH:ubiquinone oxidoreductase core subunit S7 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFS8NADH:ubiquinone oxidoreductase core subunit S8 | Bardzo często (80–99%) | W 1 chorobie |
| NDUFV1NADH:ubiquinone oxidoreductase core subunit V1 | Bardzo często (80–99%) | W 2 chorobach |
| NDUFV2NADH:ubiquinone oxidoreductase core subunit V2 | Bardzo często (80–99%) | W 1 chorobie |
| NSDHLNAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL | Bardzo często (80–99%) | W 2 chorobach |
| OTX2orthodenticle homeobox 2 | Bardzo często (80–99%) | W 2 chorobach |
| PAX6paired box 6 | Bardzo często (80–99%) | W 6 chorobach |
| PEX1peroxisomal biogenesis factor 1 | Bardzo często (80–99%) | W 1 chorobie |
| PEX10peroxisomal biogenesis factor 10 | Bardzo często (80–99%) | W 1 chorobie |
| PEX12peroxisomal biogenesis factor 12 | Bardzo często (80–99%) | W 1 chorobie |
| PEX13peroxisomal biogenesis factor 13 | Bardzo często (80–99%) | W 1 chorobie |
| PEX14peroxisomal biogenesis factor 14 | Bardzo często (80–99%) | W 1 chorobie |
| PEX16peroxisomal biogenesis factor 16 | Bardzo często (80–99%) | W 1 chorobie |
| PEX19peroxisomal biogenesis factor 19 | Bardzo często (80–99%) | W 1 chorobie |
| PEX2peroxisomal biogenesis factor 2 | Bardzo często (80–99%) | W 1 chorobie |
| PEX26peroxisomal biogenesis factor 26 | Bardzo często (80–99%) | W 1 chorobie |
| PEX3peroxisomal biogenesis factor 3 | Bardzo często (80–99%) | W 1 chorobie |
| PEX5peroxisomal biogenesis factor 5 | Bardzo często (80–99%) | W 1 chorobie |
| PEX6peroxisomal biogenesis factor 6 | Bardzo często (80–99%) | W 1 chorobie |
| PHOX2Apaired like homeobox 2A | Bardzo często (80–99%) | W 1 chorobie |
| PHOX2Bpaired like homeobox 2B | Bardzo często (80–99%) | W 1 chorobie |
| PIGLphosphatidylinositol glycan anchor biosynthesis class L | Bardzo często (80–99%) | W 2 chorobach |
| PLXND1plexin D1 | Bardzo często (80–99%) | W 1 chorobie |
| PMM2phosphomannomutase 2 | Bardzo często (80–99%) | W 1 chorobie |
| POMGNT1protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) | Bardzo często (80–99%) | W 4 chorobach |
| POMT1protein O-mannosyltransferase 1 | Bardzo często (80–99%) | W 3 chorobach |
| POMT2protein O-mannosyltransferase 2 | Bardzo często (80–99%) | W 4 chorobach |
| PRSS56serine protease 56 | Bardzo często (80–99%) | W 1 chorobie |
| PTCH1patched 1 | Bardzo często (80–99%) | W 4 chorobach |
| RAXretina and anterior neural fold homeobox | Bardzo często (80–99%) | W 1 chorobie |
| RETret proto-oncogene | Bardzo często (80–99%) | W 1 chorobie |
| REV3LREV3 like, DNA directed polymerase zeta catalytic subunit | Bardzo często (80–99%) | W 1 chorobie |
| RMRPRNA component of mitochondrial RNA processing endoribonuclease | Bardzo często (80–99%) | W 1 chorobie |
| RPGRIP1RPGR interacting protein 1 | Bardzo często (80–99%) | W 1 chorobie |
| SALL4spalt like transcription factor 4 | Bardzo często (80–99%) | W 5 chorobach |
| SIL1SIL1 nucleotide exchange factor | Bardzo często (80–99%) | W 2 chorobach |
| SIX6SIX homeobox 6 | Bardzo często (80–99%) | W 1 chorobie |
| SLC25A24solute carrier family 25 member 24 | Bardzo często (80–99%) | W 1 chorobie |
| SLC25A4solute carrier family 25 member 4 | Bardzo często (80–99%) | W 1 chorobie |
| SLC39A8solute carrier family 39 member 8 | Bardzo często (80–99%) | W 2 chorobach |
| SMG9SMG9 nonsense mediated mRNA decay factor | Bardzo często (80–99%) | W 1 chorobie |
| SOBPsine oculis binding protein homolog | Bardzo często (80–99%) | W 1 chorobie |
| SOX2SRY-box transcription factor 2 | Bardzo często (80–99%) | W 2 chorobach |
| SSR4signal sequence receptor subunit 4 | Bardzo często (80–99%) | W 2 chorobach |
| TIMMDC1translocase of inner mitochondrial membrane domain containing 1 | Bardzo często (80–99%) | W 1 chorobie |
| TKFCtriokinase and FMN cyclase | Bardzo często (80–99%) | W 1 chorobie |
| TMEM126Btransmembrane protein 126B | Bardzo często (80–99%) | W 1 chorobie |
| TMEM98transmembrane protein 98 | Bardzo często (80–99%) | W 1 chorobie |
| TUBA1Atubulin alpha 1a | Bardzo często (80–99%) | W 3 chorobach |
| TUBB2Btubulin beta 2B class IIb | Bardzo często (80–99%) | W 4 chorobach |
| TYRtyrosinase | Bardzo często (80–99%) | W 2 chorobach |
| WASF1WASP family member 1 | Bardzo często (80–99%) | W 1 chorobie |
| ABHD5abhydrolase domain containing 5, lysophosphatidic acid acyltransferase | Często (30–79%) | W 2 chorobach |
| ACO2aconitase 2 | Często (30–79%) | W 1 chorobie |
| ACOX1acyl-CoA oxidase 1 | Często (30–79%) | W 2 chorobach |
| ADAMTS15ADAM metallopeptidase with thrombospondin type 1 motif 15 | Często (30–79%) | W 1 chorobie |
| ADAMTS2ADAM metallopeptidase with thrombospondin type 1 motif 2 | Często (30–79%) | W 1 chorobie |
| ADAMTSL2ADAMTS like 2 | Często (30–79%) | W 1 chorobie |
| ADSLadenylosuccinate lyase | Często (30–79%) | W 1 chorobie |
| AFF3ALF transcription elongation factor 3 | Często (30–79%) | W 1 chorobie |
| AGO2argonaute RISC catalytic component 2 | Często (30–79%) | W 1 chorobie |
| AGTPBP1ATP/GTP binding carboxypeptidase 1 | Często (30–79%) | W 2 chorobach |
| AHCYadenosylhomocysteinase | Często (30–79%) | W 1 chorobie |
| AHDC1AT-hook DNA binding motif containing 1 | Często (30–79%) | W 2 chorobach |
| ALDH7A1aldehyde dehydrogenase 7 family member A1 | Często (30–79%) | W 1 chorobie |
| ALG1ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase | Często (30–79%) | W 1 chorobie |
| ALX3ALX homeobox 3 | Często (30–79%) | W 1 chorobie |
| AMMECR1AMMECR nuclear protein 1 | Często (30–79%) | W 2 chorobach |
| ANAPC7anaphase promoting complex subunit 7 | Często (30–79%) | W 1 chorobie |
| ANKRD11ankyrin repeat domain 11 | Często (30–79%) | W 2 chorobach |
| AP3D1adaptor related protein complex 3 subunit delta 1 | Często (30–79%) | W 2 chorobach |
| ARHGAP31Rho GTPase activating protein 31 | Często (30–79%) | W 1 chorobie |
| ARID1BAT-rich interaction domain 1B | Często (30–79%) | W 2 chorobach |
| ARID2AT-rich interaction domain 2 | Często (30–79%) | W 1 chorobie |
| ARNT2aryl hydrocarbon receptor nuclear translocator 2 | Często (30–79%) | W 1 chorobie |
| ARPC4actin related protein 2/3 complex subunit 4 | Często (30–79%) | W 1 chorobie |
| ARXaristaless related homeobox | Często (30–79%) | W 3 chorobach |
| ASXL1ASXL transcriptional regulator 1 | Często (30–79%) | W 1 chorobie |
| ASXL3ASXL transcriptional regulator 3 | Często (30–79%) | W 2 chorobach |
| ATG7autophagy related 7 | Często (30–79%) | W 1 chorobie |
| ATP2B3ATPase plasma membrane Ca2+ transporting 3 | Często (30–79%) | W 2 chorobach |
| ATP6V0A2ATPase H+ transporting V0 subunit a2 | Często (30–79%) | W 2 chorobach |
| ATP6V1AATPase H+ transporting V1 subunit A | Często (30–79%) | W 1 chorobie |
| ATP8A2ATPase phospholipid transporting 8A2 | Często (30–79%) | W 1 chorobie |
| ATP9AATPase phospholipid transporting 9A | Często (30–79%) | W 1 chorobie |
| ATXN7L3ataxin 7 like 3 | Często (30–79%) | W 1 chorobie |
| AUTS2activator of transcription and developmental regulator AUTS2 | Często (30–79%) | W 2 chorobach |
| BAZ1Bbromodomain adjacent to zinc finger domain 1B | Często (30–79%) | W 1 chorobie |
| BBS9Bardet-Biedl syndrome 9 | Często (30–79%) | W 2 chorobach |
| BCAS3BCAS3 microtubule associated cell migration factor | Często (30–79%) | W 1 chorobie |
| BICRABRD4 interacting chromatin remodeling complex associated protein | Często (30–79%) | W 1 chorobie |
| BLOC1S5biogenesis of lysosomal organelles complex 1 subunit 5 | Często (30–79%) | W 1 chorobie |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Często (30–79%) | W 4 chorobach |
| BRD4bromodomain containing 4 | Często (30–79%) | W 2 chorobach |
| BUD23BUD23 rRNA methyltransferase and ribosome maturation factor | Często (30–79%) | W 1 chorobie |
| CA8carbonic anhydrase 8 (inactive) | Często (30–79%) | W 2 chorobach |
| CACHD1cache domain containing 1 | Często (30–79%) | W 1 chorobie |
| CACNA1Bcalcium voltage-gated channel subunit alpha1 B | Często (30–79%) | W 1 chorobie |
| CACNA1Gcalcium voltage-gated channel subunit alpha1 G | Często (30–79%) | W 2 chorobach |
| CAMTA1calmodulin binding transcription activator 1 | Często (30–79%) | W 2 chorobach |
| CASKcalcium/calmodulin dependent serine protein kinase | Często (30–79%) | W 3 chorobach |
| CASZ1castor zinc finger 1 | Często (30–79%) | W 1 chorobie |
| CBLCbl proto-oncogene | Często (30–79%) | W 1 chorobie |
| CD96CD96 molecule | Często (30–79%) | W 2 chorobach |
| CDH2cadherin 2 | Często (30–79%) | W 1 chorobie |
| CDK13cyclin dependent kinase 13 | Często (30–79%) | W 1 chorobie |
| CDK8cyclin dependent kinase 8 | Często (30–79%) | W 1 chorobie |
| CEP85Lcentrosomal protein 85L | Często (30–79%) | W 1 chorobie |
| CHAMP1chromosome alignment maintaining phosphoprotein 1 | Często (30–79%) | W 1 chorobie |
| CHD3chromodomain helicase DNA binding protein 3 | Często (30–79%) | W 1 chorobie |
| CHD7chromodomain helicase DNA binding protein 7 | Często (30–79%) | W 1 chorobie |
| CLCN3Cl-/H+ antiporter 3 | Często (30–79%) | W 1 chorobie |
| CLIP2CAP-Gly domain containing linker protein 2 | Często (30–79%) | W 1 chorobie |
| CLTCL1clathrin heavy chain like 1 | Często (30–79%) | W 1 chorobie |
| CLTRNcollectrin, amino acid transport regulator | Często (30–79%) | W 1 chorobie |
| COG3component of oligomeric golgi complex 3 | Często (30–79%) | W 1 chorobie |
| COL1A2collagen type I alpha 2 chain | Często (30–79%) | W 1 chorobie |
| COQ8Acoenzyme Q8A | Często (30–79%) | W 2 chorobach |
| CPLX1complexin 1 | Często (30–79%) | W 3 chorobach |
| CPSF3cleavage and polyadenylation specific factor 3 | Często (30–79%) | W 1 chorobie |
| CTBP1C-terminal binding protein 1 | Często (30–79%) | W 2 chorobach |
| CTCFCCCTC-binding factor | Często (30–79%) | W 2 chorobach |
| DCCDCC netrin 1 receptor | Często (30–79%) | W 1 chorobie |
| DCNdecorin | Często (30–79%) | W 1 chorobie |
| DDB2damage specific DNA binding protein 2 | Często (30–79%) | W 1 chorobie |
| DDHD2DDHD domain containing 2 | Często (30–79%) | W 2 chorobach |
| DDX3XDEAD-box helicase 3 X-linked | Często (30–79%) | W 1 chorobie |
| DDX6DEAD-box helicase 6 | Często (30–79%) | W 1 chorobie |
| DHCR2424-dehydrocholesterol reductase | Często (30–79%) | W 2 chorobach |
| DHX30DExH-box helicase 30 | Często (30–79%) | W 1 chorobie |
| DLG3discs large MAGUK scaffold protein 3 | Często (30–79%) | W 1 chorobie |
| DLG4discs large MAGUK scaffold protein 4 | Często (30–79%) | W 1 chorobie |
| DLL4delta like canonical Notch ligand 4 | Często (30–79%) | W 1 chorobie |
| DNAJC30DnaJ heat shock protein family (Hsp40) member C30 | Często (30–79%) | W 1 chorobie |
| DOCK6dedicator of cytokinesis 6 | Często (30–79%) | W 2 chorobach |
| DOHHdeoxyhypusine hydroxylase | Często (30–79%) | W 1 chorobie |
| DPF2double PHD fingers 2 | Często (30–79%) | W 2 chorobach |
| DPYSL5dihydropyrimidinase like 5 | Często (30–79%) | W 1 chorobie |
| DSEdermatan sulfate epimerase | Często (30–79%) | W 1 chorobie |
| DYNC2LI1dynein cytoplasmic 2 light intermediate chain 1 | Często (30–79%) | W 1 chorobie |
| EHMT1euchromatic histone lysine methyltransferase 1 | Często (30–79%) | W 1 chorobie |
| EIF4Heukaryotic translation initiation factor 4H | Często (30–79%) | W 1 chorobie |
| ELFN1extracellular leucine rich repeat and fibronectin type III domain containing 1 | Często (30–79%) | W 1 chorobie |
| ELNelastin | Często (30–79%) | W 3 chorobach |
| EOGTEGF domain specific O-linked N-acetylglucosamine transferase | Często (30–79%) | W 1 chorobie |
| ERCC2ERCC excision repair 2, TFIIH core complex helicase subunit | Często (30–79%) | W 3 chorobach |
| ERCC3ERCC excision repair 3, TFIIH core complex helicase subunit | Często (30–79%) | W 2 chorobach |
| ERCC4ERCC excision repair 4, endonuclease catalytic subunit | Często (30–79%) | W 3 chorobach |
| ERCC5ERCC excision repair 5, endonuclease | Często (30–79%) | W 1 chorobie |
| ERCC6ERCC excision repair 6, chromatin remodeling factor | Często (30–79%) | W 5 chorobach |
| EVCEvC ciliary complex subunit 1 | Często (30–79%) | W 1 chorobie |
| EVC2EvC ciliary complex subunit 2 | Często (30–79%) | W 1 chorobie |
| EXOSC2exosome component 2 | Często (30–79%) | W 1 chorobie |
| EXOSC5exosome component 5 | Często (30–79%) | W 1 chorobie |
| EXT2exostosin glycosyltransferase 2 | Często (30–79%) | W 2 chorobach |
| FBN1fibrillin 1 | Często (30–79%) | W 4 chorobach |
| FCSKfucose kinase | Często (30–79%) | W 1 chorobie |
| FGFR1fibroblast growth factor receptor 1 | Często (30–79%) | W 3 chorobach |
| FGFR2fibroblast growth factor receptor 2 | Często (30–79%) | W 8 chorobach |
| FGFR3fibroblast growth factor receptor 3 | Często (30–79%) | W 3 chorobach |
| FGFRL1fibroblast growth factor receptor like 1 | Często (30–79%) | W 1 chorobie |
| FKBP6FKBP prolyl isomerase family member 6 (inactive) | Często (30–79%) | W 1 chorobie |
| FLI1Fli-1 proto-oncogene, ETS transcription factor | Często (30–79%) | W 1 chorobie |
| FOXC1forkhead box C1 | Często (30–79%) | W 2 chorobach |
| FOXP1forkhead box P1 | Często (30–79%) | W 2 chorobach |
| FRMD4AFERM domain containing 4A | Często (30–79%) | W 2 chorobach |
| FRMPD4FERM and PDZ domain containing 4 | Często (30–79%) | W 1 chorobie |
| GABRDgamma-aminobutyric acid type A receptor subunit delta | Często (30–79%) | W 1 chorobie |
| GLI1GLI family zinc finger 1 | Często (30–79%) | W 1 chorobie |
| GNAQG protein subunit alpha q | Często (30–79%) | W 1 chorobie |
| GNB1G protein subunit beta 1 | Często (30–79%) | W 2 chorobach |
| GPR143G protein-coupled receptor 143 | Często (30–79%) | W 1 chorobie |
| GRIN1glutamate ionotropic receptor NMDA type subunit 1 | Często (30–79%) | W 2 chorobach |
| GTF2Igeneral transcription factor IIi | Często (30–79%) | W 1 chorobie |
| GTF2IRD1GTF2I repeat domain containing 1 | Często (30–79%) | W 1 chorobie |
| GTF2IRD2GTF2I repeat domain containing 2 | Często (30–79%) | W 1 chorobie |
| GTPBP2GTP binding protein 2 | Często (30–79%) | W 1 chorobie |
| H4C3H4 clustered histone 3 | Często (30–79%) | W 1 chorobie |
| H4C9H4 clustered histone 9 | Często (30–79%) | W 1 chorobie |
| HECW2HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 | Często (30–79%) | W 1 chorobie |
| HESX1HESX homeobox 1 | Często (30–79%) | W 1 chorobie |
| HHAThedgehog acyltransferase | Często (30–79%) | W 1 chorobie |
| HIBCH3-hydroxyisobutyryl-CoA hydrolase | Często (30–79%) | W 2 chorobach |
| HIVEP2HIVEP zinc finger 2 | Często (30–79%) | W 1 chorobie |
| HNRNPH1heterogeneous nuclear ribonucleoprotein H1 | Często (30–79%) | W 1 chorobie |
| HNRNPRheterogeneous nuclear ribonucleoprotein R | Często (30–79%) | W 1 chorobie |
| HNRNPUheterogeneous nuclear ribonucleoprotein U | Często (30–79%) | W 1 chorobie |
| HRASHRas proto-oncogene, GTPase | Często (30–79%) | W 2 chorobach |
| HSD17B4hydroxysteroid 17-beta dehydrogenase 4 | Często (30–79%) | W 1 chorobie |
| HSPG2heparan sulfate proteoglycan 2 | Często (30–79%) | W 2 chorobach |
| HUWE1HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 | Często (30–79%) | W 1 chorobie |
| IFT140intraflagellar transport 140 | Często (30–79%) | W 1 chorobie |
| IKBKGinhibitor of nuclear factor kappa B kinase regulatory subunit gamma | Często (30–79%) | W 2 chorobach |
| IL1RAPL1interleukin 1 receptor accessory protein like 1 | Często (30–79%) | W 1 chorobie |
| ISCA1iron-sulfur cluster assembly 1 | Często (30–79%) | W 1 chorobie |
| KANSL1KAT8 regulatory NSL complex subunit 1 | Często (30–79%) | W 1 chorobie |
| KAT5lysine acetyltransferase 5 | Często (30–79%) | W 1 chorobie |
| KAT6Alysine acetyltransferase 6A | Często (30–79%) | W 2 chorobach |
| KCNAB2potassium voltage-gated channel subfamily A regulatory beta subunit 2 | Często (30–79%) | W 1 chorobie |
| KCNJ13potassium inwardly rectifying channel subfamily J member 13 | Często (30–79%) | W 1 chorobie |
| KCNMA1potassium calcium-activated channel subfamily M alpha 1 | Często (30–79%) | W 1 chorobie |
| KDM1Alysine demethylase 1A | Często (30–79%) | W 2 chorobach |
| KDM5Blysine demethylase 5B | Często (30–79%) | W 1 chorobie |
| KDM5Clysine demethylase 5C | Często (30–79%) | W 2 chorobach |
| KDM6Alysine demethylase 6A | Często (30–79%) | W 3 chorobach |
| KIAA0753KIAA0753 | Często (30–79%) | W 2 chorobach |
| KIDINS220kinase D interacting substrate 220 | Często (30–79%) | W 1 chorobie |
| KIF14kinesin family member 14 | Często (30–79%) | W 1 chorobie |
| KLHL20kelch like family member 20 | Często (30–79%) | W 1 chorobie |
| KMT2Alysine methyltransferase 2A | Często (30–79%) | W 1 chorobie |
| KMT2Dlysine methyltransferase 2D | Często (30–79%) | W 2 chorobach |
| KRASKRas proto-oncogene, GTPase | Często (30–79%) | W 6 chorobach |
| KRT10keratin 10 | Często (30–79%) | W 1 chorobie |
| L1CAML1 cell adhesion molecule | Często (30–79%) | W 3 chorobach |
| LAMA1laminin subunit alpha 1 | Często (30–79%) | W 2 chorobach |
| LARP7La ribonucleoprotein 7, transcriptional regulator | Często (30–79%) | W 2 chorobach |
| LETM1leucine zipper and EF-hand containing transmembrane protein 1 | Często (30–79%) | W 2 chorobach |
| LIMK1LIM domain kinase 1 | Często (30–79%) | W 1 chorobie |
| LMX1BLIM homeobox transcription factor 1 beta | Często (30–79%) | W 1 chorobie |
| LRIT3leucine rich repeat, Ig-like and transmembrane domains 3 | Często (30–79%) | W 1 chorobie |
| LRRC32leucine rich repeat containing 32 | Często (30–79%) | W 1 chorobie |
| LUZP1leucine zipper protein 1 | Często (30–79%) | W 1 chorobie |
| LZTR1leucine zipper like post translational regulator 1 | Często (30–79%) | W 2 chorobach |
| MAB21L2mab-21 like 2 | Często (30–79%) | W 1 chorobie |
| MACF1microtubule actin crosslinking factor 1 | Często (30–79%) | W 2 chorobach |
| MAGEL2MAGE family member L2 | Często (30–79%) | W 5 chorobach |
| MAN1B1mannosidase alpha class 1B member 1 | Często (30–79%) | W 1 chorobie |
| MAN2B1mannosidase alpha class 2B member 1 | Często (30–79%) | W 1 chorobie |
| MAP2K1mitogen-activated protein kinase kinase 1 | Często (30–79%) | W 2 chorobach |
| MAP3K7mitogen-activated protein kinase kinase kinase 7 | Często (30–79%) | W 1 chorobie |
| MCM3APminichromosome maintenance complex component 3 associated protein | Często (30–79%) | W 1 chorobie |
| MCTP2multiple C2 and transmembrane domain containing 2 | Często (30–79%) | W 1 chorobie |
| MDGA2MAM domain containing glycosylphosphatidylinositol anchor 2 | Często (30–79%) | W 1 chorobie |
| MDH2malate dehydrogenase 2 | Często (30–79%) | W 1 chorobie |
| MED12mediator complex subunit 12 | Często (30–79%) | W 3 chorobach |
| MED16mediator complex subunit 16 | Często (30–79%) | W 1 chorobie |
| MEGF8multiple EGF like domains 8 | Często (30–79%) | W 1 chorobie |
| METTL27methyltransferase like 27 | Często (30–79%) | W 1 chorobie |
| MID2midline 2 | Często (30–79%) | W 1 chorobie |
| MKS1MKS transition zone complex subunit 1 | Często (30–79%) | W 4 chorobach |
| MLXIPLMLX interacting protein like | Często (30–79%) | W 1 chorobie |
| MMP23Bmatrix metallopeptidase 23B | Często (30–79%) | W 1 chorobie |
| MRASmuscle RAS oncogene homolog | Często (30–79%) | W 1 chorobie |
| MRPL39mitochondrial ribosomal protein L39 | Często (30–79%) | W 1 chorobie |
| MRPS34mitochondrial ribosomal protein S34 | Często (30–79%) | W 1 chorobie |
| MTFMTmitochondrial methionyl-tRNA formyltransferase | Często (30–79%) | W 1 chorobie |
| MTRFRmitochondrial translation release factor in rescue | Często (30–79%) | W 3 chorobach |
| MYH3myosin heavy chain 3 | Często (30–79%) | W 3 chorobach |
| MYO1Hmyosin IH | Często (30–79%) | W 1 chorobie |
| NCAPG2non-SMC condensin II complex subunit G2 | Często (30–79%) | W 1 chorobie |
| NCF1neutrophil cytosolic factor 1 | Często (30–79%) | W 1 chorobie |
| NDNnecdin, MAGE family member | Często (30–79%) | W 3 chorobach |
| NFIXnuclear factor I X | Często (30–79%) | W 2 chorobach |
| NGLY1N-glycanase 1 | Często (30–79%) | W 1 chorobie |
| NHSNHS actin remodeling regulator | Często (30–79%) | W 1 chorobie |
| NONOnon-POU domain containing octamer binding | Często (30–79%) | W 2 chorobach |
| NOTCH1notch receptor 1 | Często (30–79%) | W 1 chorobie |
| NRASNRAS proto-oncogene, GTPase | Często (30–79%) | W 2 chorobach |
| NSD1nuclear receptor binding SET domain protein 1 | Często (30–79%) | W 2 chorobach |
| NSD2nuclear receptor binding SET domain protein 2 | Często (30–79%) | W 2 chorobach |
| NSUN2NOP2/Sun RNA methyltransferase 2 | Często (30–79%) | W 1 chorobie |
| OCA2OCA2 melanosomal transmembrane protein | Często (30–79%) | W 5 chorobach |
| OPHN1oligophrenin 1 | Często (30–79%) | W 2 chorobach |
| PAN2poly(A) specific ribonuclease subunit PAN2 | Często (30–79%) | W 1 chorobie |
| PCYT1Aphosphate cytidylyltransferase 1A, choline | Często (30–79%) | W 2 chorobach |
| PDPNpodoplanin | Często (30–79%) | W 1 chorobie |
| PGAP2post-GPI attachment to proteins 2 | Często (30–79%) | W 1 chorobie |
| PHF21APHD finger protein 21A | Często (30–79%) | W 1 chorobie |
| PHIPPHIP subunit of CUL4-Ring ligase complex | Często (30–79%) | W 2 chorobach |
| PIGNphosphatidylinositol glycan anchor biosynthesis class N | Często (30–79%) | W 1 chorobie |
| PLK4polo like kinase 4 | Często (30–79%) | W 1 chorobie |
| PNPT1polyribonucleotide nucleotidyltransferase 1 | Często (30–79%) | W 2 chorobach |
| POGZpogo transposable element derived with ZNF domain | Często (30–79%) | W 2 chorobach |
| POLR1BRNA polymerase I subunit B | Często (30–79%) | W 1 chorobie |
| POLR1CRNA polymerase I and III subunit C | Często (30–79%) | W 1 chorobie |
| POLR1DRNA polymerase I and III subunit D | Często (30–79%) | W 1 chorobie |
| POLR2ARNA polymerase II subunit A | Często (30–79%) | W 1 chorobie |
| POU4F1POU class 4 homeobox 1 | Często (30–79%) | W 1 chorobie |
| PPM1Dprotein phosphatase, Mg2+/Mn2+ dependent 1D | Często (30–79%) | W 1 chorobie |
| PQBP1polyglutamine binding protein 1 | Często (30–79%) | W 3 chorobach |
| PRDM13PR/SET domain 13 | Często (30–79%) | W 1 chorobie |
| PRDM16PR/SET domain 16 | Często (30–79%) | W 1 chorobie |
| PRKACAprotein kinase cAMP-activated catalytic subunit alpha | Często (30–79%) | W 1 chorobie |
| PRKACBprotein kinase cAMP-activated catalytic subunit beta | Często (30–79%) | W 1 chorobie |
| PRKCZprotein kinase C zeta | Często (30–79%) | W 1 chorobie |
| PRMT7protein arginine methyltransferase 7 | Często (30–79%) | W 2 chorobach |
| PROKR2prokineticin receptor 2 | Często (30–79%) | W 1 chorobie |
| PSMC3proteasome 26S subunit, ATPase 3 | Często (30–79%) | W 1 chorobie |
| PSMD12proteasome 26S subunit, non-ATPase 12 | Często (30–79%) | W 1 chorobie |
| PTPN11protein tyrosine phosphatase non-receptor type 11 | Często (30–79%) | W 2 chorobach |
| RAB11BRAB11B, member RAS oncogene family | Często (30–79%) | W 1 chorobie |
| RAB23RAB23, member RAS oncogene family | Często (30–79%) | W 1 chorobie |
| RAB39BRAB39B, member RAS oncogene family | Często (30–79%) | W 1 chorobie |
| RAB3GAP2RAB3 GTPase activating non-catalytic protein subunit 2 | Często (30–79%) | W 1 chorobie |
| RAF1Raf-1 proto-oncogene, serine/threonine kinase | Często (30–79%) | W 1 chorobie |
| RASA2RAS p21 protein activator 2 | Często (30–79%) | W 1 chorobie |
| RBL2RB transcriptional corepressor like 2 | Często (30–79%) | W 1 chorobie |
| RBPJrecombination signal binding protein for immunoglobulin kappa J region | Często (30–79%) | W 1 chorobie |
| RELREL proto-oncogene, NF-kB subunit | Często (30–79%) | W 1 chorobie |
| REREarginine-glutamic acid dipeptide repeats | Często (30–79%) | W 3 chorobach |
| RFC2replication factor C subunit 2 | Często (30–79%) | W 1 chorobie |
| RIC1RIC1 partner of RAB6A GEF complex | Często (30–79%) | W 1 chorobie |
| RIT1Ras like without CAAX 1 | Często (30–79%) | W 1 chorobie |
| RNU4-2RNA, U4 small nuclear 2 | Często (30–79%) | W 1 chorobie |
| RNU5B-1RNA, U5B small nuclear 1 | Często (30–79%) | W 1 chorobie |
| ROBO1roundabout guidance receptor 1 | Często (30–79%) | W 2 chorobach |
| ROBO3roundabout guidance receptor 3 | Często (30–79%) | W 1 chorobie |
| RORARAR related orphan receptor A | Często (30–79%) | W 1 chorobie |
| RPGRIP1LRPGRIP1 like | Często (30–79%) | W 3 chorobach |
| RRASRAS related | Często (30–79%) | W 1 chorobie |
| RRAS2RAS related 2 | Często (30–79%) | W 2 chorobach |
| SCNM1sodium channel modifier 1 | Często (30–79%) | W 1 chorobie |
| SEMA3Esemaphorin 3E | Często (30–79%) | W 1 chorobie |
| SETXsenataxin | Często (30–79%) | W 2 chorobach |
| SHANK3SH3 and multiple ankyrin repeat domains 3 | Często (30–79%) | W 1 chorobie |
| SHMT2serine hydroxymethyltransferase 2 | Często (30–79%) | W 1 chorobie |
| SHOC2SHOC2 leucine rich repeat scaffold protein | Często (30–79%) | W 1 chorobie |
| SHROOM4shroom family member 4 | Często (30–79%) | W 1 chorobie |
| SIM1SIM bHLH transcription factor 1 | Często (30–79%) | W 2 chorobach |
| SKISKI proto-oncogene | Często (30–79%) | W 3 chorobach |
| SKOR2SKI family transcriptional corepressor 2 | Często (30–79%) | W 1 chorobie |
| SLC38A8solute carrier family 38 member 8 | Często (30–79%) | W 1 chorobie |
| SLC44A1solute carrier family 44 member 1 | Często (30–79%) | W 1 chorobie |
| SLC6A19solute carrier family 6 member 19 | Często (30–79%) | W 1 chorobie |
| SMARCA4SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4 | Często (30–79%) | W 1 chorobie |
| SMARCB1SWI/SNF related BAF chromatin remodeling complex subunit B1 | Często (30–79%) | W 1 chorobie |
| SMARCC2SWI/SNF related BAF chromatin remodeling complex subunit C2 | Często (30–79%) | W 1 chorobie |
| SMARCD1SWI/SNF related BAF chromatin remodeling complex subunit D1 | Często (30–79%) | W 1 chorobie |
| SMARCE1SWI/SNF related BAF chromatin remodeling complex subunit E1 | Często (30–79%) | W 1 chorobie |
| SNRPNsmall nuclear ribonucleoprotein polypeptide N | Często (30–79%) | W 4 chorobach |
| SONSON DNA and RNA binding protein | Często (30–79%) | W 2 chorobach |
| SOS1SOS Ras/Rac guanine nucleotide exchange factor 1 | Często (30–79%) | W 1 chorobie |
| SOS2SOS Ras/Rho guanine nucleotide exchange factor 2 | Często (30–79%) | W 1 chorobie |
| SOX11SRY-box transcription factor 11 | Często (30–79%) | W 1 chorobie |
| SOX3SRY-box transcription factor 3 | Często (30–79%) | W 1 chorobie |
| SOX4SRY-box transcription factor 4 | Często (30–79%) | W 1 chorobie |
| SOX5SRY-box transcription factor 5 | Często (30–79%) | W 2 chorobach |
| SPENspen family transcriptional repressor | Często (30–79%) | W 1 chorobie |
| SPRED2sprouty related EVH1 domain containing 2 | Często (30–79%) | W 1 chorobie |
| SRCAPSnf2 related CREBBP activator protein | Często (30–79%) | W 3 chorobach |
| SREBF1sterol regulatory element binding transcription factor 1 | Często (30–79%) | W 1 chorobie |
| STX1Asyntaxin 1A | Często (30–79%) | W 1 chorobie |
| STXBP1syntaxin binding protein 1 | Często (30–79%) | W 1 chorobie |
| SYNGAP1synaptic Ras GTPase activating protein 1 | Często (30–79%) | W 1 chorobie |
| SYT1synaptotagmin 1 | Często (30–79%) | W 2 chorobach |
| TAF1TATA-box binding protein associated factor 1 | Często (30–79%) | W 2 chorobach |
| TBC1D23TBC1 domain family member 23 | Często (30–79%) | W 1 chorobie |
| TBC1D7TBC1 domain family member 7 | Często (30–79%) | W 1 chorobie |
| TBCKTBC1 domain containing kinase | Często (30–79%) | W 2 chorobach |
| TBL1XR1TBL1X/Y related 1 | Często (30–79%) | W 2 chorobach |
| TBL2transducin beta like 2 | Często (30–79%) | W 1 chorobie |
| TBX15T-box transcription factor 15 | Często (30–79%) | W 1 chorobie |
| TCEAL1transcription elongation factor A like 1 | Często (30–79%) | W 1 chorobie |
| TCF4transcription factor 4 | Często (30–79%) | W 2 chorobach |
| TCOF1treacle ribosome biogenesis factor 1 | Często (30–79%) | W 2 chorobach |
| TEFMtranscription elongation factor, mitochondrial | Często (30–79%) | W 1 chorobie |
| TFE3transcription factor binding to IGHM enhancer 3 | Często (30–79%) | W 1 chorobie |
| THG1LtRNA-histidine guanylyltransferase 1 like | Często (30–79%) | W 1 chorobie |
| TLK2tousled like kinase 2 | Często (30–79%) | W 1 chorobie |
| TM2D3TM2 domain containing 3 | Często (30–79%) | W 1 chorobie |
| TMCO1transmembrane and coiled-coil domains 1 | Często (30–79%) | W 2 chorobach |
| TMEM237transmembrane protein 237 | Często (30–79%) | W 4 chorobach |
| TMEM270transmembrane protein 270 | Często (30–79%) | W 1 chorobie |
| TNPO2transportin 2 | Często (30–79%) | W 1 chorobie |
| TRAPPC6Btrafficking protein particle complex subunit 6B | Często (30–79%) | W 1 chorobie |
| TRIM44TRIM family member 44 | Często (30–79%) | W 1 chorobie |
| TRPM1transient receptor potential cation channel subfamily M member 1 | Często (30–79%) | W 1 chorobie |
| TRPM3transient receptor potential cation channel subfamily M member 3 | Często (30–79%) | W 1 chorobie |
| TTI1TELO2 interacting protein 1 | Często (30–79%) | W 1 chorobie |
| TUBGCP4tubulin gamma complex component 4 | Często (30–79%) | W 1 chorobie |
| TUBGCP6tubulin gamma complex component 6 | Często (30–79%) | W 1 chorobie |
| TWIST1twist family bHLH transcription factor 1 | Często (30–79%) | W 3 chorobach |
| UBE3Aubiquitin protein ligase E3A | Często (30–79%) | W 3 chorobach |
| UBE3Bubiquitin protein ligase E3B | Często (30–79%) | W 2 chorobach |
| UBE4Bubiquitination factor E4B | Często (30–79%) | W 1 chorobie |
| VPS37DVPS37D subunit of ESCRT-I | Często (30–79%) | W 1 chorobie |
| WACWW domain containing adaptor with coiled-coil | Często (30–79%) | W 3 chorobach |
| WASHC4WASH complex subunit 4 | Często (30–79%) | W 1 chorobie |
| WBP4WW domain binding protein 4 | Często (30–79%) | W 1 chorobie |
| WDR26WD repeat domain 26 | Często (30–79%) | W 2 chorobach |
| WDR35WD repeat domain 35 | Często (30–79%) | W 1 chorobie |
| WDR81WD repeat domain 81 | Często (30–79%) | W 2 chorobach |
| WT1WT1 transcription factor | Często (30–79%) | W 1 chorobie |
| XPAXPA, DNA damage recognition and repair factor | Często (30–79%) | W 1 chorobie |
| XPCXPC complex subunit, DNA damage recognition and repair factor | Często (30–79%) | W 1 chorobie |
| XPO1exportin 1 | Często (30–79%) | W 1 chorobie |
| YME1L1YME1 like 1 ATPase | Często (30–79%) | W 1 chorobie |
| YY1YY1 transcription factor | Często (30–79%) | W 2 chorobach |
| ZBTB20zinc finger and BTB domain containing 20 | Często (30–79%) | W 1 chorobie |
| ZEB2zinc finger E-box binding homeobox 2 | Często (30–79%) | W 3 chorobach |
| ZIC1Zic family zinc finger 1 | Często (30–79%) | W 2 chorobach |
| AARS1alanyl-tRNA synthetase 1 | Czasami (5–29%) | W 1 chorobie |
| AASSaminoadipate-semialdehyde synthase | Czasami (5–29%) | W 1 chorobie |
| ABCD1ATP binding cassette subfamily D member 1 | Czasami (5–29%) | W 1 chorobie |
| ACSL4acyl-CoA synthetase long chain family member 4 | Czasami (5–29%) | W 1 chorobie |
| ADGRG1adhesion G protein-coupled receptor G1 | Czasami (5–29%) | W 1 chorobie |
| ADNPactivity dependent neuroprotector homeobox | Czasami (5–29%) | W 2 chorobach |
| ADPRSADP-ribosylserine hydrolase | Czasami (5–29%) | W 1 chorobie |
| AEBP1AE binding protein 1 | Czasami (5–29%) | W 1 chorobie |
| AFF4ALF transcription elongation factor 4 | Czasami (5–29%) | W 1 chorobie |
| AFG2AAAA ATPase AFG2A | Czasami (5–29%) | W 1 chorobie |
| AGO1argonaute RISC component 1 | Czasami (5–29%) | W 1 chorobie |
| AHI1Abelson helper integration site 1 | Czasami (5–29%) | W 2 chorobach |
| AKT1AKT serine/threonine kinase 1 | Czasami (5–29%) | W 1 chorobie |
| ALDH18A1aldehyde dehydrogenase 18 family member A1 | Czasami (5–29%) | W 3 chorobach |
| ALG11ALG11 alpha-1,2-mannosyltransferase | Czasami (5–29%) | W 2 chorobach |
| ALG12ALG12 alpha-1,6-mannosyltransferase | Czasami (5–29%) | W 1 chorobie |
| ALG6ALG6 alpha-1,3-glucosyltransferase | Czasami (5–29%) | W 2 chorobach |
| AMPD2adenosine monophosphate deaminase 2 | Czasami (5–29%) | W 1 chorobie |
| ANKRD17ankyrin repeat domain 17 | Czasami (5–29%) | W 1 chorobie |
| AP1G1adaptor related protein complex 1 subunit gamma 1 | Czasami (5–29%) | W 1 chorobie |
| ARCN1archain 1 coat protein complex I subunit delta | Czasami (5–29%) | W 1 chorobie |
| ARL13BARF like GTPase 13B | Czasami (5–29%) | W 1 chorobie |
| ARL3ARF like GTPase 3 | Czasami (5–29%) | W 1 chorobie |
| ARL6ARF like GTPase 6 | Czasami (5–29%) | W 2 chorobach |
| ARMC9armadillo repeat containing 9 | Czasami (5–29%) | W 1 chorobie |
| ARVCFARVCF delta catenin family member | Czasami (5–29%) | W 1 chorobie |
| ASCC3activating signal cointegrator 1 complex subunit 3 | Czasami (5–29%) | W 1 chorobie |
| ATOH7atonal bHLH transcription factor 7 | Czasami (5–29%) | W 1 chorobie |
| ATP5F1AATP synthase F1 subunit alpha | Czasami (5–29%) | W 1 chorobie |
| ATP5F1DATP synthase F1 subunit delta | Czasami (5–29%) | W 1 chorobie |
| ATP5F1EATP synthase F1 subunit epsilon | Czasami (5–29%) | W 1 chorobie |
| ATP5MKATP synthase membrane subunit k | Czasami (5–29%) | W 1 chorobie |
| ATP5POATP synthase peripheral stalk subunit OSCP | Czasami (5–29%) | W 1 chorobie |
| ATPAF2ATP synthase mitochondrial F1 complex assembly factor 2 | Czasami (5–29%) | W 1 chorobie |
| B9D1B9 domain containing 1 | Czasami (5–29%) | W 1 chorobie |
| B9D2B9 domain containing 2 | Czasami (5–29%) | W 1 chorobie |
| BAP1BRCA1 associated deubiquitinase 1 | Czasami (5–29%) | W 1 chorobie |
| BBIP1BBSome interacting protein 1 | Czasami (5–29%) | W 1 chorobie |
| BBS1Bardet-Biedl syndrome 1 | Czasami (5–29%) | W 2 chorobach |
| BBS10Bardet-Biedl syndrome 10 | Czasami (5–29%) | W 1 chorobie |
| BBS12Bardet-Biedl syndrome 12 | Czasami (5–29%) | W 1 chorobie |
| BBS2Bardet-Biedl syndrome 2 | Czasami (5–29%) | W 1 chorobie |
| BBS4Bardet-Biedl syndrome 4 | Czasami (5–29%) | W 1 chorobie |
| BBS5Bardet-Biedl syndrome 5 | Czasami (5–29%) | W 1 chorobie |
| BBS7Bardet-Biedl syndrome 7 | Czasami (5–29%) | W 1 chorobie |
| BCORL1BCL6 corepressor like 1 | Czasami (5–29%) | W 1 chorobie |
| BRCA1BRCA1 DNA repair associated | Czasami (5–29%) | W 1 chorobie |
| BRCA2BRCA2 DNA repair associated | Czasami (5–29%) | W 1 chorobie |
| BRF1BRF1 general transcription factor IIIB subunit | Czasami (5–29%) | W 2 chorobach |
| BRIP1BRCA1 interacting DNA helicase 1 | Czasami (5–29%) | W 1 chorobie |
| CABP4calcium binding protein 4 | Czasami (5–29%) | W 1 chorobie |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Czasami (5–29%) | W 1 chorobie |
| CAMK2Acalcium/calmodulin dependent protein kinase II alpha | Czasami (5–29%) | W 1 chorobie |
| CAMK2Bcalcium/calmodulin dependent protein kinase II beta | Czasami (5–29%) | W 1 chorobie |
| CAPRIN1cell cycle associated protein 1 | Czasami (5–29%) | W 1 chorobie |
| CARS1cysteinyl-tRNA synthetase 1 | Czasami (5–29%) | W 1 chorobie |
| CBScystathionine beta-synthase | Czasami (5–29%) | W 1 chorobie |
| CBY1chibby 1, beta catenin antagonist | Czasami (5–29%) | W 1 chorobie |
| CDC42cell division cycle 42 | Czasami (5–29%) | W 1 chorobie |
| CDC42BPBCDC42 binding protein kinase beta | Czasami (5–29%) | W 1 chorobie |
| CDC45cell division cycle 45 | Czasami (5–29%) | W 1 chorobie |
| CDH3cadherin 3 | Czasami (5–29%) | W 1 chorobie |
| CDK10cyclin dependent kinase 10 | Czasami (5–29%) | W 1 chorobie |
| CDONcell adhesion associated, oncogene regulated | Czasami (5–29%) | W 1 chorobie |
| CEP104centrosomal protein 104 | Czasami (5–29%) | W 1 chorobie |
| CEP120centrosomal protein 120 | Czasami (5–29%) | W 3 chorobach |
| CEP152centrosomal protein 152 | Czasami (5–29%) | W 1 chorobie |
| CEP19centrosomal protein 19 | Czasami (5–29%) | W 1 chorobie |
| CEP290centrosomal protein 290 | Czasami (5–29%) | W 2 chorobach |
| CEP41centrosomal protein 41 | Czasami (5–29%) | W 2 chorobach |
| CEP83centrosomal protein 83 | Czasami (5–29%) | W 1 chorobie |
| CFAP418cilia and flagella associated protein 418 | Czasami (5–29%) | W 1 chorobie |
| CHD6chromodomain helicase DNA binding protein 6 | Czasami (5–29%) | W 1 chorobie |
| CHRNA7cholinergic receptor nicotinic alpha 7 subunit | Czasami (5–29%) | W 2 chorobach |
| CHRNGcholinergic receptor nicotinic gamma subunit | Czasami (5–29%) | W 1 chorobie |
| CLCN4Cl-/H+ antiporter 4 | Czasami (5–29%) | W 2 chorobach |
| CLDN16claudin 16 | Czasami (5–29%) | W 1 chorobie |
| CNOT3CCR4-NOT transcription complex subunit 3 | Czasami (5–29%) | W 1 chorobie |
| COG5component of oligomeric golgi complex 5 | Czasami (5–29%) | W 1 chorobie |
| COL11A1collagen type XI alpha 1 chain | Czasami (5–29%) | W 1 chorobie |
| COL18A1collagen type XVIII alpha 1 chain | Czasami (5–29%) | W 1 chorobie |
| COMTcatechol-O-methyltransferase | Czasami (5–29%) | W 1 chorobie |
| CPLANE1ciliogenesis and planar polarity effector complex subunit 1 | Czasami (5–29%) | W 1 chorobie |
| CRIPTOcripto, EGF-CFC family member | Czasami (5–29%) | W 1 chorobie |
| CSPP1centrosome and spindle pole associated protein 1 | Czasami (5–29%) | W 2 chorobach |
| CTNNB1catenin beta 1 | Czasami (5–29%) | W 2 chorobach |
| DACT1dishevelled binding antagonist of beta catenin 1 | Czasami (5–29%) | W 1 chorobie |
| DBR1debranching RNA lariats 1 | Czasami (5–29%) | W 1 chorobie |
| DGUOKdeoxyguanosine kinase | Czasami (5–29%) | W 1 chorobie |
| DHCR77-dehydrocholesterol reductase | Czasami (5–29%) | W 2 chorobach |
| DHODHdihydroorotate dehydrogenase (quinone) | Czasami (5–29%) | W 1 chorobie |
| DHX37DEAH-box helicase 37 | Czasami (5–29%) | W 1 chorobie |
| DISP1dispatched RND transporter family member 1 | Czasami (5–29%) | W 1 chorobie |
| DLATdihydrolipoamide S-acetyltransferase | Czasami (5–29%) | W 1 chorobie |
| DLL1delta like canonical Notch ligand 1 | Czasami (5–29%) | W 1 chorobie |
| DNM1Ldynamin 1L | Czasami (5–29%) | W 1 chorobie |
| DOLKdolichol kinase | Czasami (5–29%) | W 1 chorobie |
| DOT1LDOT1 like histone lysine methyltransferase | Czasami (5–29%) | W 1 chorobie |
| DPAGT1dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 | Czasami (5–29%) | W 1 chorobie |
| DPM1dolichyl-phosphate mannosyltransferase subunit 1, catalytic | Czasami (5–29%) | W 2 chorobach |
| DPM2dolichyl-phosphate mannosyltransferase subunit 2, regulatory | Czasami (5–29%) | W 2 chorobach |
| DPYDdihydropyrimidine dehydrogenase | Czasami (5–29%) | W 1 chorobie |
| DVL1dishevelled segment polarity protein 1 | Czasami (5–29%) | W 1 chorobie |
| DVL3dishevelled segment polarity protein 3 | Czasami (5–29%) | W 1 chorobie |
| DYRK1Adual specificity tyrosine phosphorylation regulated kinase 1A | Czasami (5–29%) | W 2 chorobach |
| EDEM3ER degradation enhancing alpha-mannosidase like protein 3 | Czasami (5–29%) | W 1 chorobie |
| EEFSECeukaryotic elongation factor, selenocysteine-tRNA specific | Czasami (5–29%) | W 1 chorobie |
| EIF2AK3eukaryotic translation initiation factor 2 alpha kinase 3 | Czasami (5–29%) | W 1 chorobie |
| EIF3Feukaryotic translation initiation factor 3 subunit F | Czasami (5–29%) | W 1 chorobie |
| ELOVL4ELOVL fatty acid elongase 4 | Czasami (5–29%) | W 1 chorobie |
| EMC1ER membrane protein complex subunit 1 | Czasami (5–29%) | W 1 chorobie |
| ERCC1ERCC excision repair 1, endonuclease non-catalytic subunit | Czasami (5–29%) | W 1 chorobie |
| ERCC8ERCC excision repair 8, CSA ubiquitin ligase complex subunit | Czasami (5–29%) | W 4 chorobach |
| EXOSC3exosome component 3 | Czasami (5–29%) | W 2 chorobach |
| EXOSC8exosome component 8 | Czasami (5–29%) | W 1 chorobie |
| EXOSC9exosome component 9 | Czasami (5–29%) | W 1 chorobie |
| FA2Hfatty acid 2-hydroxylase | Czasami (5–29%) | W 2 chorobach |
| FAAP100FA core complex associated protein 100 | Czasami (5–29%) | W 1 chorobie |
| FAM50Afamily with sequence similarity 50 member A | Czasami (5–29%) | W 1 chorobie |
| FANCAFA complementation group A | Czasami (5–29%) | W 2 chorobach |
| FANCBFA complementation group B | Czasami (5–29%) | W 1 chorobie |
| FANCCFA complementation group C | Czasami (5–29%) | W 2 chorobach |
| FANCD2FA complementation group D2 | Czasami (5–29%) | W 2 chorobach |
| FANCEFA complementation group E | Czasami (5–29%) | W 2 chorobach |
| FANCFFA complementation group F | Czasami (5–29%) | W 1 chorobie |
| FANCGFA complementation group G | Czasami (5–29%) | W 1 chorobie |
| FANCIFA complementation group I | Czasami (5–29%) | W 1 chorobie |
| FANCLFA complementation group L | Czasami (5–29%) | W 1 chorobie |
| FANCMFA complementation group M | Czasami (5–29%) | W 1 chorobie |
| FARS2phenylalanyl-tRNA synthetase 2, mitochondrial | Czasami (5–29%) | W 1 chorobie |
| FBLN5fibulin 5 | Czasami (5–29%) | W 1 chorobie |
| FBXL3F-box and leucine rich repeat protein 3 | Czasami (5–29%) | W 1 chorobie |
| FBXL4F-box and leucine rich repeat protein 4 | Czasami (5–29%) | W 1 chorobie |
| FBXO22F-box protein 22 | Czasami (5–29%) | W 1 chorobie |
| FBXW11F-box and WD repeat domain containing 11 | Czasami (5–29%) | W 1 chorobie |
| FBXW7F-box and WD repeat domain containing 7 | Czasami (5–29%) | W 1 chorobie |
| FGD1FYVE, RhoGEF and PH domain containing 1 | Czasami (5–29%) | W 2 chorobach |
| FGF14fibroblast growth factor 14 | Czasami (5–29%) | W 2 chorobach |
| FGF3fibroblast growth factor 3 | Czasami (5–29%) | W 1 chorobie |
| FGF8fibroblast growth factor 8 | Czasami (5–29%) | W 1 chorobie |
| FIBPFGF1 intracellular binding protein | Czasami (5–29%) | W 2 chorobach |
| FIG4FIG4 phosphoinositide 5-phosphatase | Czasami (5–29%) | W 1 chorobie |
| FLNAfilamin A | Czasami (5–29%) | W 2 chorobach |
| FMR1fragile X messenger ribonucleoprotein 1 | Czasami (5–29%) | W 1 chorobie |
| FOXH1forkhead box H1 | Czasami (5–29%) | W 1 chorobie |
| FOXL2forkhead box L2 | Czasami (5–29%) | W 2 chorobach |
| FRMD5FERM domain containing 5 | Czasami (5–29%) | W 1 chorobie |
| FZD2frizzled class receptor 2 | Czasami (5–29%) | W 1 chorobie |
| FZD4frizzled class receptor 4 | Czasami (5–29%) | W 2 chorobach |
| FZD5frizzled class receptor 5 | Czasami (5–29%) | W 1 chorobie |
| GAS1growth arrest specific 1 | Czasami (5–29%) | W 1 chorobie |
| GATA4GATA binding protein 4 | Czasami (5–29%) | W 1 chorobie |
| GDF5growth differentiation factor 5 | Czasami (5–29%) | W 1 chorobie |
| GGT1gamma-glutamyltransferase 1 | Czasami (5–29%) | W 2 chorobach |
| GJA1gap junction protein alpha 1 | Czasami (5–29%) | W 1 chorobie |
| GJA5gap junction protein alpha 5 | Czasami (5–29%) | W 1 chorobie |
| GJA8gap junction protein alpha 8 | Czasami (5–29%) | W 1 chorobie |
| GLI2GLI family zinc finger 2 | Czasami (5–29%) | W 1 chorobie |
| GMPPAGDP-mannose pyrophosphorylase A | Czasami (5–29%) | W 1 chorobie |
| GNASGNAS complex locus | Czasami (5–29%) | W 1 chorobie |
| GP1BBglycoprotein Ib platelet subunit beta | Czasami (5–29%) | W 1 chorobie |
| GPC4glypican 4 | Czasami (5–29%) | W 1 chorobie |
| GPR179G protein-coupled receptor 179 | Czasami (5–29%) | W 1 chorobie |
| GRIA4glutamate ionotropic receptor AMPA type subunit 4 | Czasami (5–29%) | W 1 chorobie |
| GRIK2glutamate ionotropic receptor kainate type subunit 2 | Czasami (5–29%) | W 1 chorobie |
| GTF2E2general transcription factor IIE subunit 2 | Czasami (5–29%) | W 1 chorobie |
| GTF2H5general transcription factor IIH subunit 5 | Czasami (5–29%) | W 1 chorobie |
| H1-4H1.4 linker histone, cluster member | Czasami (5–29%) | W 1 chorobie |
| H3-3AH3.3 histone A | Czasami (5–29%) | W 1 chorobie |
| H4C5H4 clustered histone 5 | Czasami (5–29%) | W 1 chorobie |
| HDAC8histone deacetylase 8 | Czasami (5–29%) | W 1 chorobie |
| HID1HID1 domain containing | Czasami (5–29%) | W 1 chorobie |
| HIRAhistone cell cycle regulator | Czasami (5–29%) | W 1 chorobie |
| HK1hexokinase 1 | Czasami (5–29%) | W 1 chorobie |
| HOXA13homeobox A13 | Czasami (5–29%) | W 1 chorobie |
| HPS5HPS5 biogenesis of lysosomal organelles complex 2 subunit 2 | Czasami (5–29%) | W 1 chorobie |
| HPS6HPS6 biogenesis of lysosomal organelles complex 2 subunit 3 | Czasami (5–29%) | W 1 chorobie |
| HYLS1HYLS1 centriolar and ciliogenesis associated | Czasami (5–29%) | W 1 chorobie |
| IDH3Aisocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha | Czasami (5–29%) | W 1 chorobie |
| IFT172intraflagellar transport 172 | Czasami (5–29%) | W 1 chorobie |
| IFT27intraflagellar transport 27 | Czasami (5–29%) | W 1 chorobie |
| IFT54intraflagellar transport 54 | Czasami (5–29%) | W 1 chorobie |
| IFT74intraflagellar transport 74 | Czasami (5–29%) | W 2 chorobach |
| INTS1integrator complex subunit 1 | Czasami (5–29%) | W 1 chorobie |
| IQSEC2IQ motif and Sec7 domain ArfGEF 2 | Czasami (5–29%) | W 2 chorobach |
| JMJD1Cjumonji domain containing 1C | Czasami (5–29%) | W 1 chorobie |
| KATNIPkatanin interacting protein | Czasami (5–29%) | W 1 chorobie |
| KCNE5potassium voltage-gated channel subfamily E regulatory subunit 5 | Czasami (5–29%) | W 1 chorobie |
| KCNV2potassium voltage-gated channel modifier subfamily V member 2 | Czasami (5–29%) | W 1 chorobie |
| KDM5Alysine demethylase 5A | Czasami (5–29%) | W 1 chorobie |
| KDM6Blysine demethylase 6B | Czasami (5–29%) | W 1 chorobie |
| KIAA0586KIAA0586 | Czasami (5–29%) | W 1 chorobie |
| KIF15kinesin family member 15 | Czasami (5–29%) | W 1 chorobie |
| KIF22kinesin family member 22 | Czasami (5–29%) | W 1 chorobie |
| KIF7kinesin family member 7 | Czasami (5–29%) | W 1 chorobie |
| KLF13KLF transcription factor 13 | Czasami (5–29%) | W 1 chorobie |
| KMT2Blysine methyltransferase 2B | Czasami (5–29%) | W 3 chorobach |
| KRT25keratin 25 | Czasami (5–29%) | W 1 chorobie |
| KRT71keratin 71 | Czasami (5–29%) | W 1 chorobie |
| KRT74keratin 74 | Czasami (5–29%) | W 1 chorobie |
| LAMB2laminin subunit beta 2 | Czasami (5–29%) | W 1 chorobie |
| LARS2leucyl-tRNA synthetase 2, mitochondrial | Czasami (5–29%) | W 1 chorobie |
| LIPHlipase H | Czasami (5–29%) | W 1 chorobie |
| LONP1lon peptidase 1, mitochondrial | Czasami (5–29%) | W 1 chorobie |
| LPAR6lysophosphatidic acid receptor 6 | Czasami (5–29%) | W 1 chorobie |
| LRP5LDL receptor related protein 5 | Czasami (5–29%) | W 1 chorobie |
| LYSTlysosomal trafficking regulator | Czasami (5–29%) | W 2 chorobach |
| LZTFL1leucine zipper transcription factor like 1 | Czasami (5–29%) | W 1 chorobie |
| MAD2L2mitotic arrest deficient 2 like 2 | Czasami (5–29%) | W 1 chorobie |
| MADDMAP kinase activating death domain | Czasami (5–29%) | W 1 chorobie |
| MAPRE2microtubule associated protein RP/EB family member 2 | Czasami (5–29%) | W 1 chorobie |
| MARK2microtubule affinity regulating kinase 2 | Czasami (5–29%) | W 1 chorobie |
| MAU2MAU2 sister chromatid cohesion factor | Czasami (5–29%) | W 2 chorobach |
| MED11mediator complex subunit 11 | Czasami (5–29%) | W 1 chorobie |
| MED12Lmediator complex subunit 12L | Czasami (5–29%) | W 1 chorobie |
| MED25mediator complex subunit 25 | Czasami (5–29%) | W 2 chorobach |
| MEF2Cmyocyte enhancer factor 2C | Czasami (5–29%) | W 1 chorobie |
| MKKSMKKS centrosomal shuttling protein | Czasami (5–29%) | W 1 chorobie |
| MPLKIPM-phase specific PLK1 interacting protein | Czasami (5–29%) | W 1 chorobie |
| MSL2MSL complex subunit 2 | Czasami (5–29%) | W 1 chorobie |
| MT-ATP6mitochondrially encoded ATP synthase membrane subunit 6 | Czasami (5–29%) | W 1 chorobie |
| MT-ATP8mitochondrially encoded ATP synthase membrane subunit 8 | Czasami (5–29%) | W 1 chorobie |
| MTORmechanistic target of rapamycin kinase | Czasami (5–29%) | W 2 chorobach |
| MYO5Amyosin VA | Czasami (5–29%) | W 1 chorobie |
| NAA60N-alpha-acetyltransferase 60, NatF catalytic subunit | Czasami (5–29%) | W 1 chorobie |
| NANSN-acetylneuraminate synthase | Czasami (5–29%) | W 1 chorobie |
| NAV3neuron navigator 3 | Czasami (5–29%) | W 1 chorobie |
| NAXENAD(P)HX epimerase | Czasami (5–29%) | W 2 chorobach |
| NBASNBAS subunit of NRZ tethering complex | Czasami (5–29%) | W 1 chorobie |
| NDST1N-deacetylase and N-sulfotransferase 1 | Czasami (5–29%) | W 1 chorobie |
| NELFAnegative elongation factor complex member A | Czasami (5–29%) | W 1 chorobie |
| NEU1neuraminidase 1 | Czasami (5–29%) | W 2 chorobach |
| NF1neurofibromin 1 | Czasami (5–29%) | W 1 chorobie |
| NFU1NFU1 iron-sulfur cluster scaffold | Czasami (5–29%) | W 1 chorobie |
| NIPBLNIPBL cohesin loading factor | Czasami (5–29%) | W 2 chorobach |
| NKX6-2NK6 homeobox 2 | Czasami (5–29%) | W 1 chorobie |
| NODALnodal growth differentiation factor | Czasami (5–29%) | W 1 chorobie |
| NOGnoggin | Czasami (5–29%) | W 2 chorobach |
| NOTCH3notch receptor 3 | Czasami (5–29%) | W 1 chorobie |
| NPHP1nephrocystin 1 | Czasami (5–29%) | W 2 chorobach |
| NRCAMneuronal cell adhesion molecule | Czasami (5–29%) | W 1 chorobie |
| NT5C25'-nucleotidase, cytosolic II | Czasami (5–29%) | W 1 chorobie |
| NXNnucleoredoxin | Czasami (5–29%) | W 1 chorobie |
| OCRLOCRL inositol polyphosphate-5-phosphatase | Czasami (5–29%) | W 1 chorobie |
| OFD1OFD1 centriole and centriolar satellite protein | Czasami (5–29%) | W 1 chorobie |
| OPA1OPA1 mitochondrial dynamin like GTPase | Czasami (5–29%) | W 2 chorobach |
| OPLAH5-oxoprolinase, ATP-hydrolysing | Czasami (5–29%) | W 1 chorobie |
| OTUD5OTU deubiquitinase 5 | Czasami (5–29%) | W 1 chorobie |
| PACS2phosphofurin acidic cluster sorting protein 2 | Czasami (5–29%) | W 1 chorobie |
| PAK2p21 (RAC1) activated kinase 2 | Czasami (5–29%) | W 1 chorobie |
| PALB2partner and localizer of BRCA2 | Czasami (5–29%) | W 1 chorobie |
| PAX2paired box 2 | Czasami (5–29%) | W 2 chorobach |
| PAX3paired box 3 | Czasami (5–29%) | W 1 chorobie |
| PCDHGC4protocadherin gamma subfamily C, 4 | Czasami (5–29%) | W 1 chorobie |
| PDE6Dphosphodiesterase 6D | Czasami (5–29%) | W 1 chorobie |
| PIBF1progesterone immunomodulatory binding factor 1 | Czasami (5–29%) | W 1 chorobie |
| PIGGphosphatidylinositol glycan anchor biosynthesis class G (EMM blood group) | Czasami (5–29%) | W 1 chorobie |
| PIK3R5phosphoinositide-3-kinase regulatory subunit 5 | Czasami (5–29%) | W 1 chorobie |
| PLA2G6phospholipase A2 group VI | Czasami (5–29%) | W 1 chorobie |
| PLXNA1plexin A1 | Czasami (5–29%) | W 1 chorobie |
| PNPLA6patatin like domain 6, lysophospholipase | Czasami (5–29%) | W 1 chorobie |
| POLR1ARNA polymerase I subunit A | Czasami (5–29%) | W 1 chorobie |
| POLRMTRNA polymerase mitochondrial | Czasami (5–29%) | W 1 chorobie |
| POMKprotein O-mannose kinase | Czasami (5–29%) | W 1 chorobie |
| PORCNporcupine O-acyltransferase | Czasami (5–29%) | W 2 chorobach |
| POU3F4POU class 3 homeobox 4 | Czasami (5–29%) | W 1 chorobie |
| PPP1R12Aprotein phosphatase 1 regulatory subunit 12A | Czasami (5–29%) | W 1 chorobie |
| PPP2R5Cprotein phosphatase 2 regulatory subunit B'gamma | Czasami (5–29%) | W 1 chorobie |
| PPP2R5Dprotein phosphatase 2 regulatory subunit B'delta | Czasami (5–29%) | W 2 chorobach |
| PTCH2patched 2 | Czasami (5–29%) | W 1 chorobie |
| PUF60poly(U) binding splicing factor 60 | Czasami (5–29%) | W 2 chorobach |
| PURApurine rich element binding protein A | Czasami (5–29%) | W 1 chorobie |
| RAD21RAD21 cohesin complex component | Czasami (5–29%) | W 1 chorobie |
| RAD51RAD51 recombinase | Czasami (5–29%) | W 1 chorobie |
| RAD51CRAD51 paralog C | Czasami (5–29%) | W 1 chorobie |
| RBM8ARNA binding motif protein 8A | Czasami (5–29%) | W 1 chorobie |
| RFWD3ring finger and WD repeat domain 3 | Czasami (5–29%) | W 1 chorobie |
| RHOAras homolog family member A | Czasami (5–29%) | W 1 chorobie |
| RNF113Aring finger protein 113A | Czasami (5–29%) | W 1 chorobie |
| RNF135ring finger protein 135 | Czasami (5–29%) | W 1 chorobie |
| RNU2-2RNA, U2 small nuclear 2 | Czasami (5–29%) | W 1 chorobie |
| ROR2ROR family WNT receptor 2 | Czasami (5–29%) | W 2 chorobach |
| RPS6KA3ribosomal protein S6 kinase A3 | Czasami (5–29%) | W 1 chorobie |
| RREB1ras responsive element binding protein 1 | Czasami (5–29%) | W 1 chorobie |
| RS1retinoschisin 1 | Czasami (5–29%) | W 1 chorobie |
| RSPRY1ring finger and SPRY domain containing 1 | Czasami (5–29%) | W 2 chorobach |
| SALL1spalt like transcription factor 1 | Czasami (5–29%) | W 1 chorobie |
| SAMD9Lsterile alpha motif domain containing 9 like | Czasami (5–29%) | W 1 chorobie |
| SARDHsarcosine dehydrogenase | Czasami (5–29%) | W 1 chorobie |
| SATB2SATB homeobox 2 | Czasami (5–29%) | W 2 chorobach |
| SBF1SET binding factor 1 | Czasami (5–29%) | W 1 chorobie |
| SCAPERS-phase cyclin A associated protein in the ER | Czasami (5–29%) | W 1 chorobie |
| SCLT1sodium channel and clathrin linker 1 | Czasami (5–29%) | W 1 chorobie |
| SCUBE3signal peptide, CUB domain and EGF like domain containing 3 | Czasami (5–29%) | W 1 chorobie |
| SDCCAG8SHH signaling and ciliogenesis regulator SDCCAG8 | Czasami (5–29%) | W 1 chorobie |
| SEC24CSEC24 homolog C, COPII component | Czasami (5–29%) | W 1 chorobie |
| SETSET nuclear proto-oncogene | Czasami (5–29%) | W 1 chorobie |
| SETBP1SET binding protein 1 | Czasami (5–29%) | W 1 chorobie |
| SETD5SET domain containing 5 | Czasami (5–29%) | W 1 chorobie |
| SF3B2splicing factor 3b subunit 2 | Czasami (5–29%) | W 1 chorobie |
| SGSM3small G protein signaling modulator 3 | Czasami (5–29%) | W 1 chorobie |
| SH3TC2SH3 domain and tetratricopeptide repeats 2 | Czasami (5–29%) | W 1 chorobie |
| SHHsonic hedgehog signaling molecule | Czasami (5–29%) | W 1 chorobie |
| SIAH1siah E3 ubiquitin protein ligase 1 | Czasami (5–29%) | W 1 chorobie |
| SIX3SIX homeobox 3 | Czasami (5–29%) | W 1 chorobie |
| SLC12A6solute carrier family 12 member 6 | Czasami (5–29%) | W 1 chorobie |
| SLC25A46solute carrier family 25 member 46 | Czasami (5–29%) | W 1 chorobie |
| SLC2A1solute carrier family 2 member 1 | Czasami (5–29%) | W 1 chorobie |
| SLC2A10solute carrier family 2 member 10 | Czasami (5–29%) | W 1 chorobie |
| SLC35A2solute carrier family 35 member A2 | Czasami (5–29%) | W 1 chorobie |
| SLC9A7solute carrier family 9 member A7 | Czasami (5–29%) | W 1 chorobie |
| SLX4SLX4 structure-specific endonuclease subunit | Czasami (5–29%) | W 1 chorobie |
| SMAD4SMAD family member 4 | Czasami (5–29%) | W 1 chorobie |
| SMC1Astructural maintenance of chromosomes 1A | Czasami (5–29%) | W 1 chorobie |
| SMC3structural maintenance of chromosomes 3 | Czasami (5–29%) | W 1 chorobie |
| SMG8SMG8 nonsense mediated mRNA decay factor | Czasami (5–29%) | W 1 chorobie |
| SPECC1Lsperm antigen with calponin homology and coiled-coil domains 1 like | Czasami (5–29%) | W 1 chorobie |
| SPG11SPG11 vesicle trafficking associated, spatacsin | Czasami (5–29%) | W 1 chorobie |
| SPOPspeckle type BTB/POZ protein | Czasami (5–29%) | W 1 chorobie |
| SPTAN1spectrin alpha, non-erythrocytic 1 | Czasami (5–29%) | W 1 chorobie |
| SRPK3SRSF protein kinase 3 | Czasami (5–29%) | W 1 chorobie |
| SRRM2serine/arginine repetitive matrix 2 | Czasami (5–29%) | W 1 chorobie |
| STAG1STAG1 cohesin complex component | Czasami (5–29%) | W 1 chorobie |
| STT3ASTT3 oligosaccharyltransferase complex catalytic subunit A | Czasami (5–29%) | W 1 chorobie |
| SUCLG1succinate-CoA ligase GDP/ADP-forming subunit alpha | Czasami (5–29%) | W 1 chorobie |
| SUFUSUFU negative regulator of hedgehog signaling | Czasami (5–29%) | W 3 chorobach |
| SUPT16HSPT16 homolog, facilitates chromatin remodeling subunit | Czasami (5–29%) | W 1 chorobie |
| TAOK1TAO kinase 1 | Czasami (5–29%) | W 1 chorobie |
| TARS1threonyl-tRNA synthetase 1 | Czasami (5–29%) | W 1 chorobie |
| TASP1taspase 1 | Czasami (5–29%) | W 1 chorobie |
| TBC1D32TBC1 domain family member 32 | Czasami (5–29%) | W 2 chorobach |
| TBCDtubulin folding cofactor D | Czasami (5–29%) | W 1 chorobie |
| TBX1T-box transcription factor 1 | Czasami (5–29%) | W 1 chorobie |
| TBX4T-box transcription factor 4 | Czasami (5–29%) | W 1 chorobie |
| TCF12transcription factor 12 | Czasami (5–29%) | W 1 chorobie |
| TCTN1tectonic family member 1 | Czasami (5–29%) | W 1 chorobie |
| TCTN2tectonic family member 2 | Czasami (5–29%) | W 1 chorobie |
| TCTN3tectonic family member 3 | Czasami (5–29%) | W 1 chorobie |
| TET3tet methylcytosine dioxygenase 3 | Czasami (5–29%) | W 1 chorobie |
| TFAP2Atranscription factor AP-2 alpha | Czasami (5–29%) | W 2 chorobach |
| TFAP2Btranscription factor AP-2 beta | Czasami (5–29%) | W 2 chorobach |
| TGIF1TGFB induced factor homeobox 1 | Czasami (5–29%) | W 1 chorobie |
| THOC2THO complex subunit 2 | Czasami (5–29%) | W 2 chorobach |
| TKTtransketolase | Czasami (5–29%) | W 1 chorobie |
| TMEM126Atransmembrane protein 126A | Czasami (5–29%) | W 1 chorobie |
| TMEM138transmembrane protein 138 | Czasami (5–29%) | W 1 chorobie |
| TMEM218transmembrane protein 218 | Czasami (5–29%) | W 1 chorobie |
| TMEM222transmembrane protein 222 | Czasami (5–29%) | W 1 chorobie |
| TMEM231transmembrane protein 231 | Czasami (5–29%) | W 1 chorobie |
| TMEM240transmembrane protein 240 | Czasami (5–29%) | W 1 chorobie |
| TMEM53transmembrane protein 53 | Czasami (5–29%) | W 1 chorobie |
| TMEM63Ctransmembrane protein 63C | Czasami (5–29%) | W 1 chorobie |
| TMEM67transmembrane protein 67 | Czasami (5–29%) | W 3 chorobach |
| TMEM94transmembrane protein 94 | Czasami (5–29%) | W 1 chorobie |
| TOGARAM1TOG array regulator of axonemal microtubules 1 | Czasami (5–29%) | W 1 chorobie |
| TRAF7TNF receptor associated factor 7 | Czasami (5–29%) | W 1 chorobie |
| TRAPPC11trafficking protein particle complex subunit 11 | Czasami (5–29%) | W 2 chorobach |
| TRIM32tripartite motif containing 32 | Czasami (5–29%) | W 1 chorobie |
| TRIM37tripartite motif containing 37 | Czasami (5–29%) | W 1 chorobie |
| TRIOtrio Rho guanine nucleotide exchange factor | Czasami (5–29%) | W 1 chorobie |
| TRIP11thyroid hormone receptor interactor 11 | Czasami (5–29%) | W 1 chorobie |
| TSEN15tRNA splicing endonuclease subunit 15 | Czasami (5–29%) | W 1 chorobie |
| TTC8tetratricopeptide repeat domain 8 | Czasami (5–29%) | W 1 chorobie |
| TTI2TELO2 interacting protein 2 | Czasami (5–29%) | W 2 chorobach |
| TWIST2twist family bHLH transcription factor 2 | Czasami (5–29%) | W 1 chorobie |
| TYRP1tyrosinase related protein 1 | Czasami (5–29%) | W 2 chorobach |
| UBE2Aubiquitin conjugating enzyme E2 A | Czasami (5–29%) | W 1 chorobie |
| UBE2Tubiquitin conjugating enzyme E2 T | Czasami (5–29%) | W 1 chorobie |
| UFD1ubiquitin recognition factor in ER associated degradation 1 | Czasami (5–29%) | W 1 chorobie |
| USP7ubiquitin specific peptidase 7 | Czasami (5–29%) | W 2 chorobach |
| USP9Xubiquitin specific peptidase 9 X-linked | Czasami (5–29%) | W 2 chorobach |
| VPS13Bvacuolar protein sorting 13 homolog B | Czasami (5–29%) | W 1 chorobie |
| VRK1VRK serine/threonine kinase 1 | Czasami (5–29%) | W 1 chorobie |
| WDPCPWD repeat containing planar cell polarity effector | Czasami (5–29%) | W 1 chorobie |
| WDR11WD repeat domain 11 | Czasami (5–29%) | W 1 chorobie |
| WDR83OSWD repeat domain 83 opposite strand | Czasami (5–29%) | W 1 chorobie |
| WNT5AWnt family member 5A | Czasami (5–29%) | W 1 chorobie |
| XRCC2X-ray repair cross complementing 2 | Czasami (5–29%) | W 1 chorobie |
| YAP1Yes1 associated transcriptional regulator | Czasami (5–29%) | W 1 chorobie |
| ZC4H2zinc finger C4H2-type containing | Czasami (5–29%) | W 1 chorobie |
| ZFXzinc finger protein X-linked | Czasami (5–29%) | W 1 chorobie |
| ZIC2Zic family zinc finger 2 | Czasami (5–29%) | W 1 chorobie |
| ZNF292zinc finger protein 292 | Czasami (5–29%) | W 1 chorobie |
| ZNF423zinc finger protein 423 | Czasami (5–29%) | W 1 chorobie |
| ZRSR2zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 | Czasami (5–29%) | W 1 chorobie |
| ZSWIM6zinc finger SWIM-type containing 6 | Czasami (5–29%) | W 1 chorobie |
| ACBD6acyl-CoA binding domain containing 6 | Rzadko (1–4%) | W 1 chorobie |
| ADA2adenosine deaminase 2 | Rzadko (1–4%) | W 1 chorobie |
| ALDH3A2aldehyde dehydrogenase 3 family member A2 | Rzadko (1–4%) | W 1 chorobie |
| AP4B1adaptor related protein complex 4 subunit beta 1 | Rzadko (1–4%) | W 1 chorobie |
| AP4E1adaptor related protein complex 4 subunit epsilon 1 | Rzadko (1–4%) | W 1 chorobie |
| AP4M1adaptor related protein complex 4 subunit mu 1 | Rzadko (1–4%) | W 2 chorobach |
| AP4S1adaptor related protein complex 4 subunit sigma 1 | Rzadko (1–4%) | W 1 chorobie |
| APC2APC regulator of Wnt signaling pathway 2 | Rzadko (1–4%) | W 1 chorobie |
| ATP6V1B2ATPase H+ transporting V1 subunit B2 | Rzadko (1–4%) | W 1 chorobie |
| CACNA1Ecalcium voltage-gated channel subunit alpha1 E | Rzadko (1–4%) | W 1 chorobie |
| CDKL5cyclin dependent kinase like 5 | Rzadko (1–4%) | W 1 chorobie |
| COL11A2collagen type XI alpha 2 chain | Rzadko (1–4%) | W 1 chorobie |
| COL2A1collagen type II alpha 1 chain | Rzadko (1–4%) | W 1 chorobie |
| CTSKcathepsin K | Rzadko (1–4%) | W 1 chorobie |
| CYP1B1cytochrome P450 family 1 subfamily B member 1 | Rzadko (1–4%) | W 1 chorobie |
| DMXL2Dmx like 2 | Rzadko (1–4%) | W 1 chorobie |
| FN1fibronectin 1 | Rzadko (1–4%) | W 1 chorobie |
| FOXE3forkhead box E3 | Rzadko (1–4%) | W 1 chorobie |
| GATA1GATA binding protein 1 | Rzadko (1–4%) | W 1 chorobie |
| GNAO1G protein subunit alpha o1 | Rzadko (1–4%) | W 1 chorobie |
| GRK1G protein-coupled receptor kinase 1 | Rzadko (1–4%) | W 1 chorobie |
| GRM7glutamate metabotropic receptor 7 | Rzadko (1–4%) | W 1 chorobie |
| HEATR3HEAT repeat containing 3 | Rzadko (1–4%) | W 1 chorobie |
| KCNA1potassium voltage-gated channel subfamily A member 1 | Rzadko (1–4%) | W 1 chorobie |
| LGI1leucine rich glioma inactivated 1 | Rzadko (1–4%) | W 1 chorobie |
| MID1midline 1 | Rzadko (1–4%) | W 1 chorobie |
| NEUROD2neuronal differentiation 2 | Rzadko (1–4%) | W 1 chorobie |
| PAHphenylalanine hydroxylase | Rzadko (1–4%) | W 1 chorobie |
| PIGPphosphatidylinositol glycan anchor biosynthesis class P | Rzadko (1–4%) | W 1 chorobie |
| PIGQphosphatidylinositol glycan anchor biosynthesis class Q | Rzadko (1–4%) | W 1 chorobie |
| PITX2paired like homeodomain 2 | Rzadko (1–4%) | W 2 chorobach |
| PLOD1procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 | Rzadko (1–4%) | W 1 chorobie |
| PNKPpolynucleotide kinase 3'-phosphatase | Rzadko (1–4%) | W 1 chorobie |
| PTBP1polypyrimidine tract binding protein 1 | Rzadko (1–4%) | W 1 chorobie |
| RHOBTB2Rho related BTB domain containing 2 | Rzadko (1–4%) | W 1 chorobie |
| RPL11ribosomal protein L11 | Rzadko (1–4%) | W 1 chorobie |
| RPL15ribosomal protein L15 | Rzadko (1–4%) | W 1 chorobie |
| RPL18ribosomal protein L18 | Rzadko (1–4%) | W 1 chorobie |
| RPL26ribosomal protein L26 | Rzadko (1–4%) | W 1 chorobie |
| RPL27ribosomal protein L27 | Rzadko (1–4%) | W 1 chorobie |
| RPL31ribosomal protein L31 | Rzadko (1–4%) | W 1 chorobie |
| RPL35ribosomal protein L35 | Rzadko (1–4%) | W 1 chorobie |
| RPL35Aribosomal protein L35a | Rzadko (1–4%) | W 1 chorobie |
| RPL5ribosomal protein L5 | Rzadko (1–4%) | W 1 chorobie |
| RPL8ribosomal protein L8 | Rzadko (1–4%) | W 1 chorobie |
| RPL9ribosomal protein L9 | Rzadko (1–4%) | W 1 chorobie |
| RPS10ribosomal protein S10 | Rzadko (1–4%) | W 1 chorobie |
| RPS15Aribosomal protein S15a | Rzadko (1–4%) | W 1 chorobie |
| RPS17ribosomal protein S17 | Rzadko (1–4%) | W 1 chorobie |
| RPS19ribosomal protein S19 | Rzadko (1–4%) | W 2 chorobach |
| RPS20ribosomal protein S20 | Rzadko (1–4%) | W 1 chorobie |
| RPS24ribosomal protein S24 | Rzadko (1–4%) | W 1 chorobie |
| RPS26ribosomal protein S26 | Rzadko (1–4%) | W 1 chorobie |
| RPS27ribosomal protein S27 | Rzadko (1–4%) | W 1 chorobie |
| RPS28ribosomal protein S28 | Rzadko (1–4%) | W 1 chorobie |
| RPS29ribosomal protein S29 | Rzadko (1–4%) | W 1 chorobie |
| RPS7ribosomal protein S7 | Rzadko (1–4%) | W 1 chorobie |
| SAGS-antigen visual arrestin | Rzadko (1–4%) | W 1 chorobie |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Rzadko (1–4%) | W 1 chorobie |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Rzadko (1–4%) | W 1 chorobie |
| SIK1salt inducible kinase 1 | Rzadko (1–4%) | W 1 chorobie |
| SLC25A22solute carrier family 25 member 22 | Rzadko (1–4%) | W 1 chorobie |
| SLC32A1solute carrier family 32 member 1 | Rzadko (1–4%) | W 1 chorobie |
| SPTBN1spectrin beta, non-erythrocytic 1 | Rzadko (1–4%) | W 1 chorobie |
| TBC1D24TBC1 domain family member 24 | Rzadko (1–4%) | W 1 chorobie |
| TRIM8tripartite motif containing 8 | Rzadko (1–4%) | W 1 chorobie |
| TSR2TSR2 ribosome maturation factor | Rzadko (1–4%) | W 1 chorobie |
| ABCC8ATP binding cassette subfamily C member 8 | Nie odnotowano | W 1 chorobie |
| ADD3adducin 3 | Nie odnotowano | W 1 chorobie |
| ALG3ALG3 alpha-1,3- mannosyltransferase | Nie odnotowano | W 1 chorobie |
| AP3B1adaptor related protein complex 3 subunit beta 1 | Nie odnotowano | W 1 chorobie |
| ATRATR checkpoint kinase | Nie odnotowano | W 1 chorobie |
| BLTP1bridge-like lipid transfer protein family member 1 | Nie odnotowano | W 1 chorobie |
| CACNA2D2calcium voltage-gated channel auxiliary subunit alpha2delta 2 | Nie odnotowano | W 1 chorobie |
| CCDC174coiled-coil domain containing 174 | Nie odnotowano | W 1 chorobie |
| CCDC28Bcoiled-coil domain containing 28B | Nie odnotowano | W 1 chorobie |
| CDCA7cell division cycle associated 7 | Nie odnotowano | W 1 chorobie |
| CHATcholine O-acetyltransferase | Nie odnotowano | W 1 chorobie |
| CHRNEcholinergic receptor nicotinic epsilon subunit | Nie odnotowano | W 2 chorobach |
| CLDN19claudin 19 | Nie odnotowano | W 1 chorobie |
| COLEC11collectin subfamily member 11 | Nie odnotowano | W 1 chorobie |
| CRYAAcrystallin alpha A | Nie odnotowano | W 1 chorobie |
| CYB5R3cytochrome b5 reductase 3 | Nie odnotowano | W 1 chorobie |
| DKC1dyskerin pseudouridine synthase 1 | Nie odnotowano | W 1 chorobie |
| DNMT3ADNA methyltransferase 3 alpha | Nie odnotowano | W 1 chorobie |
| EIF2S3eukaryotic translation initiation factor 2 subunit gamma | Nie odnotowano | W 1 chorobie |
| ERLIN2ER lipid raft associated 2 | Nie odnotowano | W 1 chorobie |
| EZH2enhancer of zeste 2 polycomb repressive complex 2 subunit | Nie odnotowano | W 1 chorobie |
| GFPT1glutamine--fructose-6-phosphate transaminase 1 | Nie odnotowano | W 1 chorobie |
| GJB6gap junction protein beta 6 | Nie odnotowano | W 1 chorobie |
| GKglycerol kinase | Nie odnotowano | W 1 chorobie |
| GLRX5glutaredoxin 5 | Nie odnotowano | W 1 chorobie |
| GMNNgeminin DNA replication inhibitor | Nie odnotowano | W 1 chorobie |
| HACE1HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 | Nie odnotowano | W 1 chorobie |
| HERC2HECT and RLD domain containing E3 ubiquitin protein ligase 2 | Nie odnotowano | W 2 chorobach |
| IARS2isoleucyl-tRNA synthetase 2, mitochondrial | Nie odnotowano | W 1 chorobie |
| IGF1Rinsulin like growth factor 1 receptor | Nie odnotowano | W 1 chorobie |
| INPP5Kinositol polyphosphate-5-phosphatase K | Nie odnotowano | W 1 chorobie |
| JAG1jagged canonical Notch ligand 1 | Nie odnotowano | W 1 chorobie |
| L2HGDHL-2-hydroxyglutarate dehydrogenase | Nie odnotowano | W 1 chorobie |
| LRPPRCleucine rich pentatricopeptide repeat containing | Nie odnotowano | W 1 chorobie |
| MC1Rmelanocortin 1 receptor | Nie odnotowano | W 1 chorobie |
| MED13Lmediator complex subunit 13L | Nie odnotowano | W 1 chorobie |
| MKRN3makorin ring finger protein 3 | Nie odnotowano | W 1 chorobie |
| MN1MN1 proto-oncogene, transcriptional regulator | Nie odnotowano | W 1 chorobie |
| MPDU1mannose-P-dolichol utilization defect 1 | Nie odnotowano | W 1 chorobie |
| MPDZmultiple PDZ domain crumbs cell polarity complex component | Nie odnotowano | W 1 chorobie |
| MUSKmuscle associated receptor tyrosine kinase | Nie odnotowano | W 1 chorobie |
| NPAP1nuclear pore associated protein 1 | Nie odnotowano | W 1 chorobie |
| NRXN1neurexin 1 | Nie odnotowano | W 1 chorobie |
| ORC1origin recognition complex subunit 1 | Nie odnotowano | W 1 chorobie |
| OSGEPO-sialoglycoprotein endopeptidase | Nie odnotowano | W 1 chorobie |
| PACS1phosphofurin acidic cluster sorting protein 1 | Nie odnotowano | W 1 chorobie |
| PBX1PBX homeobox 1 | Nie odnotowano | W 1 chorobie |
| PIEZO2piezo type mechanosensitive ion channel component 2 | Nie odnotowano | W 2 chorobach |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Nie odnotowano | W 1 chorobie |
| PRSS12serine protease 12 | Nie odnotowano | W 1 chorobie |
| PWAR1Prader Willi/Angelman region RNA 1 | Nie odnotowano | W 1 chorobie |
| PWRN1Prader-Willi region non-protein coding RNA 1 | Nie odnotowano | W 1 chorobie |
| RECQL4RecQ like helicase 4 | Nie odnotowano | W 2 chorobach |
| SGPL1sphingosine-1-phosphate lyase 1 | Nie odnotowano | W 1 chorobie |
| SNIP1Smad nuclear interacting protein 1 | Nie odnotowano | W 1 chorobie |
| SNORD115-1small nucleolar RNA, C/D box 115-1 | Nie odnotowano | W 1 chorobie |
| SNORD116-1small nucleolar RNA, C/D box 116-1 | Nie odnotowano | W 1 chorobie |
| STRADASTE20 related adaptor alpha | Nie odnotowano | W 1 chorobie |
| SUCLA2succinate-CoA ligase ADP-forming subunit beta | Nie odnotowano | W 1 chorobie |
| TCF20transcription factor 20 | Nie odnotowano | W 1 chorobie |
| TDO2tryptophan 2,3-dioxygenase | Nie odnotowano | W 1 chorobie |
| TGFBItransforming growth factor beta induced | Nie odnotowano | W 2 chorobach |
| TREX1three prime repair exonuclease 1 | Nie odnotowano | W 1 chorobie |
| TRIP12thyroid hormone receptor interactor 12 | Nie odnotowano | W 1 chorobie |
| UBR1ubiquitin protein ligase E3 component n-recognin 1 | Nie odnotowano | W 1 chorobie |
| VAMP1vesicle associated membrane protein 1 | Nie odnotowano | W 1 chorobie |
| WARS2tryptophanyl tRNA synthetase 2, mitochondrial | Nie odnotowano | W 1 chorobie |
| WDR73WD repeat domain 73 | Nie odnotowano | W 1 chorobie |
| WNK3WNK lysine deficient protein kinase 3 | Nie odnotowano | W 1 chorobie |
| YARS2tyrosyl-tRNA synthetase 2 | Nie odnotowano | W 1 chorobie |
| ZDHHC9zDHHC palmitoyltransferase 9 | Nie odnotowano | W 1 chorobie |
Jak często występuje wśród osób z jedną z chorób związanych z tym genem, najczęściej spośród wszystkich, według danych Human Phenotype Ontology. Te strony opisują cechy i badania, na których się opierają; nie są diagnozą, a w sprawie objawów należy zwrócić się do lekarza lub doradcy genetycznego.
Cechy podrzędne
Cechy nadrzędne
Skąd pochodzą te dane
- Human Phenotype Ontology, wydanie 2026-09-01: cecha, jej nazwy, definicja oraz geny z nią powiązane. Więcej informacji znajdą Państwo na stronie hpo.jax.org.
- Wydanie danych 2026.10.16-c6eea6bf.
Jeden test. Odpowiedzi na całe życie.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni